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ABSTRACT

Olsen, David R.; M.S., University of Rhode Island,
1983.

Collagenase and Elastase Activities in Human and

Murine Cancer Cells and Their Modulation by Dimethylformamide.

Major Professor:

Dr. Clinton O. Chichester.

The transformation from carcinoma in situ to invasive carcinoma occurs when tumor cells traverse extracellular matracies allowing them to move into parenchymal tissues.

Tumor invasion may be aided by the

secretion of collagen and elastin degrading proteases
from tumor and tumor-associated cells.
~

In this stud y

the production of Type I and Type V collagen degrading
activities and elastolytic activities by DLD-1 human
colon carcinoma cells, B16-F10 murine melanoma cells,
and normal human dermal fibroblasts was examined.

DLD-1

cells and normal fibroblasts produced similarly high
levels of collagenolytic activity.

DLD-1 cells also

produced high levels of elastinolytic activity; this
activity was found exclusively in the extracellular
medium.

DLD-1 cells and normal fibroblasts produced

more collagen and elastin degrading activity than did
B16-F10 melanoma cells, a cell line characterized as
highly metastatic.

The Type I and Type V collagenolytic

ii

activities from DLD-1 cells were separated and characterized
using DEAE cellulose chromatography and gel filtration
chromatography.

The Type I collagenolytic activity appeared

to be an anionic protein at pH 8.3, and two forms of the
enzyme were detected, one with a molecular weight of 60,000
and the other with a molecular weight of 35,000 daltons.
The Type V collageno-ytic activity was a cationic protein
at pH 8.3 and two forms of this activity were detected, one
with a molecular weight of 80,000 and the second with a
molecular weight of 54,000 daltons.

The effect of the polar solvent, dimethylformamide
(DMF) on the production of collagen and elastin degrading
activities was studied using cultured DLD-1 cells.

DMF

treated cells produced significantly higher levels of
Type I collagenolytic, Type V collagenolytic and cellassociated elastase activities than did control cells.
DMF treatment had no significant effect on media elastase
levels.

Treatment of DLD-1 cells with DMF elevated the

cellular levels of protein and RNA while these same cells
had less DNA per cell.

DMF treated cells were also able

to synthesize protein at a significantly faster rate than
control cells.

This increased rate of protein synthesis

may account for part of the increased production of connective tissue degrading enzymes seen in DMF treated cells.

iii

However, the effect of DMF on enzyme production was still
present when the cells were treated with cycloheximide.
The failure of cycloheximide to prevent the DMF induced
increase in enzyme activity suggests that the effect of
DMF is not entirely dependent on protein synthesis.
data suggest that DLD-1

hu.~an

These

colon carcinoma cells pro-

duce at least two different collagen degrading enzymes
and that DMF treatment may facilitate the invasive movement of cancer cells during the matastatic process by
increasing the secretion of connective tissue degrading
enzymes.

iv
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INTRODUCTION

The metastatic growth of secondary neoplasms is a
major problem facing the oncologist because the pharmacological agents and medical interventions available
cannot sufficiently control this spread.

The development

of multiple metastatic foci leads to the loss of the normal function of the invaded tissues or organs and ultimately results in death.

The metastatic process begins

when tumor cells or tumor emboli disseminate from the
primary tumor mass and invade the vasculature entering
the circulation.

The transported tumor cells arrest and

invade the parenchymal tissue of adjacent organs, proliferate and develop into secondary metastases.

During

the invasion phase of metastasis, connective tissue
matracies are traversed.

Electron micrographs of the

invaded regions reveal the local dissolution of basement
membranes (Birbeck and Wheatly, 1965).

The mechanism of

basement membrane destruction is uncertain.

The extracellular matrix (ECM) is composed of several
macromolecules including elastin, collagen, and proteoglycans.

Elastin and collagen are resistant to degrada-

tion by most proteases.

The only enzymes which can

degrade collagen are collagenases.

Enzymes which specifi-

2

cally degrade elastin are termed elastases.

Elastase activity is associated with several tumor
associated cells and tumor cell lines (Mainardi et al,
1980a; Kao et al, 1982).

Collagenases are also synthesized

by several tumor and tumor associated cells (Horwitz et al,
1977; Mainardi et al, 1980a,b; O'Grady et al, 1982) and
recently collagenases specific for the different types of
collagen have been identified in the medium of certain
tumor cell lines (Liotta et al, 1981a,b; Salo et al, 1983).
During invasion, elastases and collagenases may be involved
in the local destruction of basement membranes and stromal
tissues.

In this study Types I and V collagen degrading activities and elastase activities were measured in several
tumor cell lines.

The collagenolytic activities which

were secreted by cultured DLD-1 human colon carcinoma
cells were analyzed by ion exchange chromatography and gel
filtration chromatography to determine if different
enzymes were responsible for the degradation of Types I
and V collagen.

The results of these studies may indicate

that destruction of ECM components by invading tumor cells
results from the action of more than one specific degradative enzyme.

3

A novel attempt to control the spread of cancer has
been the use of biological inducers as chemotherapeutic
agents.

Biological inducers are compounds which induce

malignant cancer cells to differentiate into benign cells
(Sachs, 1981).

One such compound, dimethylformamide (DMF)

has induced a human colon carcinama cell line, DLD-1, to
differentiate in vitro and these treated cells have a
reduced tumorigenic capacity in vivo (Dexter et al, 1979).
This study will also examine the effects of DMF treatment
on the levels of connective tissue degrading proteases in
the DLD-1 cell line.

The reduction in tumorigenicity

seen with DMF may be paralleled by a decrease in the cell's
ability to invade host tissues.

4

LITERATURE SURVEY

Metastasis

Metastasis is a multistep process in which cells
derived from a primary tumor detach and are transported
to a distant site where they form a secondary tumor
(Poste and Fidler, 1980).

The metastatic process is

initiated when cells or clumps of cells dissociate from
the primary tumor and enter blood or lymph vessels.

The

tumor cells interact with host cells as they are transported by the circulation or lymph.

During this process

some of the tumor cells may be destroyed by host defense
~

mechanisms (Old et al, 1961).
~

stops

The circulation of tumor cells

~

when they encounter a vessel which is too small

to allow passage (Ziedman, 1961) or when they attach to
vascular endothelium due to cell-cell interactions
(Winkelhade and Nicolson, 1976).

The cells may exit

the vessel at this point, invade surrounding tissue, proliferate, and develop into a secondary tumor.

Alterna-

tively the arrested cells may be engulfed and destroyed
by host macrophages and lymphocytes (Vose, 1980; Hibbs
et al, 1977).

5

The intravenous injection of mice with syngeneic tumor
cells is an experimental model of metastasis.

This model

is employed to study various aspects of the metastatic
process including the organ distribution of blood borne
tumor cells (Fidler, 1973).

The growth of tumors in

specific organs following intravenous injection of cells
has been demonstrated with several cell lines (Kinsey,
1960; Fidler and Nicoloson, 1976; Nicoloson and Winkelhade, 1975; Brunson et al, 1978).

Cell types which meta-

stasize to specific organs and variants of the same parent
line which have different capacities to form tumor nodules
following intravenous injection exhibit difference in
their cell surface components (Dobrassy et al, 1981;
~

Brunson et al, 1978; Raz et al, 1980).
~

~

~

Cell lines which

are characterized as "highly metastatic" following intravenous injection have greater quantities of cell surface
sialic acid, increased levels of sialyltransferase and
other cellular glycosidase activities (Dobrassy et al,
1981).

Sialic acid is a component of cell surface glyco-

proteins involved in cell-cell and cell-substratum
adhesion.

Others have used the intravenous injection

model with different tumor cell lines and noted random
growth of metastases (Proctor, 1976).

Tumor nodules

arose in organs where capillary beds were first encountered.

6

Models of metastasis which employ intravenously
injected cells are inadequate because they do not allow
the examination of the entire metastatic process.

They

bypass the first step of metastasis when cells break off
the primary tumor and invade the vasculature.

In the

future better models will further our understanding of
the pathogenesis of metastasis.

Invasion

During invasion tumor cells traverse stromal tissue
and blood vessels to infiltrate the parenchyma of host
organs.
~ ally

The invading cells then proliferate to eventu-

form secondary tumors.

The mechanisms involved in

the invasive movement of tumor cells is not completely
understood.

Invasion may occur as the result of mechan-

ical pressures exerted by rapidly proliferating tumor
cells (Eaves, 1973).
regions of increased

The fast growing tumors create
pressur~

and invasion occurs at

points where the host tissues were weakest.

Infiltra-

tion of host tissues may also result from tumor cell
products acting on stromal tissues and blood vessels
(Fidler et al, 1978).

Tumor cells synthesize and secrete

proteases capable of degrading the host ECM (Dresden et
al, 1972; Hashimoto et al, 1973).

Areas where the matrix

7

is weakened will then be invaded by proliferating tumor
cells.

Invasion of target organs by malignant tumor

cells in vitro can be inhibited when the incubation
medium contains several types of protease inhibitors
(Latner et al, 1973).

Stromal tissues and blood vessels are partially
composed of the structural proteins collagen and elastin,
these proteins are degraded by specific enzymes called
collagenases and elastases.

Analysis of the media from

cultured tumor cells has confirmed the presence of collagenase and elastase activities (Liotta et al, 1979; Kao
et al, 1982; O'Grady et al, 1982).
......_

These enzymes may aid

invading tumor cells but this has not been proven.

In-

vasion most likely results from a combination of mechanical forces exerted by proliferating tumor cells and degradative enzymes secreted by tumor and tumor associated
cells.

Modulation of Tumor Cell Growth

Tumor cells established in vitro are less differentiated than the normal cell-type from which they
originated (Market, 1968).

The decreased extent of

differentiation characteristic

of malignant cells is

8

thought to result from an imbalance between the number of
genes which express and suppress normal growth and differentiation (Rabinowitz and Sachs, 1970).

In vitro induc-

tion of differentiation of tumor cells has been achieved
using several compounds.

Dimethylsulfoxide has induced

erythroleukemia cells to differentiate resulting in their
synthesis of hemoglobin (Friend et al, 1971).
adenosine

3~,

5~

Cyclic

monophosphate and dibutyryl cyclic

adenosine monophosphate stimulated cellular differentiation leading to increased melanin synthesis, cellular
enlargement and increased dendrite formation in B16 melanoma cells (Kreider et al, 1973).

Hexamethylene bisace-

tamide induced morphological changes (cell elongation) and
maturational changes in a malignant mesenchymal cell line
(Rabson et al, 1977).

The agent caused a shift from the

synthesis of Type III collagen to the synthesis of Type I
collagen.

Dimethylformamide (DMF) has induced morpholo-

gical changes and reduced the tumorigenicity of rhabdomyosarcoma cells (Dexter, 1977).

DMF has also induced

the loss of tumorigenicity and clonogenicity of the human
colon carcinoma cell line DLD-1 (Dexter et al, 1979).
DLD-1 cells treated in vitro with DMF have exhibited a
decreased expression of tumor associated antigens and an
increase in the amount of normal colonic surface antigen
(Hager et al, 1980).

DMF alters several in vitro growth

9

characteristics of DLD-1 cells causing their doubling time
to increase and their saturation density to decrease
(Dexter et al, 1979).

These data suggest that DMF has

induced a malignant cell type to differentiate and mature
into a cell-type with benign phenotypes.

The effect of

biological inducers such as DMF on the invasive capacity
of tumor cells has not been studied, these experiments
may provide information on the modulation of the metastatic potential of tumor cells.

Collagen Heterogenity

Collagens are a group of triple-helical, inflexible,
..... rod-shaped proteins found in mammalian connective tissues .
Collagens have a 20% imino acid (proline and hydroxyproline) content, a 30% glycine content and are glycosylated
(Burgeson, 1982).

The precursor subunits of collagen,

procollagen alpha (pro°') chains undergo several posttransla t ional modifications.

The first modification is

the enzymatic hydroxylation of specific prolyl and lysyl
residues (Prockop and Juva, 1965).

Carbohydrate moieties

are then added to some of the hydroxylysyl residues by
galactosyl and glucosyltransferases (Spiro and Spiro, 1971).
These events are followed by intra- and interchain disulfide bond fomration and packaging of proo{ chains into

10

a triple helix (Ditto and Prockop, 1973).

Triple helical

procollagen molecules are packaged into secretory granules in the Golgi complex and are ready for export (Weinstock and Leblond, 1974).

Extracellularly procollagen

molecules are modified by procollagen peptidases (Lapiere
et al, 1971).

These enzymes cleave off non-helical pep-

tides from the NH

2

and COOH terminal ends of procollagen

to form collagen.

In the extracellular matrix collagen fibers aggregate to form orderly fibrils via parallel lengthwise
interactions (Prockop et al, 1979).

The fibrils are

stabilized by intra- and intermolecular covalent crosslinks formed following oxidative deamination of lysine
and hydroxylysine residues by the enzyme lysyl oxidase
(Pinell and Martin, 1968).

Crosslinks are formed when

enzymatically produced aldehydes react with lysine or
hydroxylysine residues (Siegel and Martin, 1970).

Cross-

link formation increases the collagen fibrils resistance
to degradation by collagenase (Vater et al, 1979).

Presently five major collagen types and several minor
collagenous proteins have been identified (Burgeson, 1982).
The major collagens, designated Types I, II, III, IV, and
V, differ in subunit composition, carbohydrate content,

11

tissue distribution and arrangement in the extracellular
matrix (Bornstein and Sage, 1980).

The minor collagenous

proteins which have been partially characterized include
the E and F chains of human hyaline cartilage (Burgeson
and Hollister, 1979), the HMW and LMW collagenous fragments of chick hyaline cartilage (Reese et al, 1979), EC
collagen synthesized by cultured endothelial cells (Sage
et al, 1980) and a collagenous fragment isolated from
placental tissue (Furuto and Miller, 1980).

Types I, II, and III collagen, collectively called
the interstitial collagens, are the major structural components of connective tissues.
~are

The interstitial collagens

composed of three subunit polypeptide chains called

alpha

(q ) chains.

Alpha chains from Types I, I I, and I I I

collagen differ in amino acid composition and size,
additionally the three~ chains of Type I collagen are
not similar.

Type I collagen is composed of two different

subunits designatedo< l(I)
composed of three idential
formulao< l(II) 3 •
configuration of

2

o\2(I).

a'.

Type II collagen is

chains represented by the

Type III collagen has a molecular

P'( 1 (I I I) 3 (Bornstein and Sage, 198 0).

12

The basement membrane collagens Types IV and V make up
a minor portion of the total collagenous fraction of the
extracellular matrix.

Type IV collagen has been localized

to the basement membranes of most tissues (Bornstein and
Sage, 1980).

Type IV collagen is composed of three o{ chains

which are biochemically distinct from those of the interstitial collagens.
and are designated
1979).

Two different

o(

O'\

chains have been identified

l(IV) and~ 2(IV) (Sage and Bornstein,

Type IV collagen

o(

chains contain more 4-hydroxypro-

line than 3-hydroxyproline which is present in interstitial
collagens.

They contain more carbohydrate residues than

interstitial collagens and these chains are stabilized by
disulfide bonds (Sage et al, 1979).

The IV collagen

cl;

chains are wound into a triple helix and form fibers which
are different from other collagenous fibers.

Type IV colla-

gen fibers are composed of four distinct regions; at one end
there is a non-collagenous globular peptide called NCl, the
second region is the major triple helical domain which contains several regions where the triple helix is interrupted.
The third region is another non-collagenous domain called
NC2, and the other end of the fiber is a collagenous peptide
called the 7S domain (Timpl et al, 1981; Schuppan et al,
1980; Glanville and Rauter, 1981).

Type IV collagen fibers

do not appear to be processed by procollagen peptidases
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(Dehm and Kefalides, 1978).

These fibers exhibit a speci-

fic orientation in basement membranes.

The globular

heads (NCl) of two fibers are connected in a non-covalent
manner while the 78 domains of four fibers from aggregates (Timpl et al, 1981).

The association of four 78

domains yields a structure termed 78 collagen (Risteli
et al, 1980).

7S collagen is more stable than other

collagenous proteins due to extensive disulfide bonding
between subunits and it is partially resistant to digestion by bacterial collagenase.

Type V collagen, discovered in 1976 by two groups of
investigators (Chung et al, 1976; Burgeson et al, 1976)
represents approximately 5 % of the total collagenous
fraction of tissues.

Immunofluorenscence has localized

Type V collagen in basement membranes and on the pericellular surface of cells (Madri and Furthmayr, 1980; Gay
et al, 1981).

This type of collagen has been isolated

from several tissues including vasculature, skin, synovium,
gingiva, liver, tendon, placenta, bone, lung, and muscle
(Bornstein and Sage, 1980).

The exact function of Type V

collagen is not known, it may be involved in cell migration (Stenn et al, 1979) and may play a role in stabilizing
cytoskeletal architecture.
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The physical properties of Type V collagen are similar to the other collegens.

Four different Type V colla-

gen

o\ chains

o(

l(V),o\ 2(V), P°\3(V), and d\4(V) (Sage and Bornstein,

have been isolated and are designated

1979; Fessler et al, 1983).

Presently, the exact molecular

configuration of Type V collagen is not established.

Most

preparations are composed of two~ l(V) chains and one
~ 2(V) chain, the ~3(V) orC"\4(V) chains may be present

depending on the tissue source (Rhodes and Miller, 1978;
Bentz et al, 1978; Sage and Bornstein, 1979; Fessler et al,
1983).

Type V collagen is glycosylated like the other

collagens, it's carbohydrate content is intermediate
between the interstitial and basement membran e collagens
--..

(Burgeson et al, 1976).

--

It is secreted into the extra-

cellular matrix in a procollagen form and und erg oes limited
proteolysis by procollagen peptidases (Kumamoto and
Fessler, 1981).

The globular extension peptides which

remain intact are larger than those of Types I, II, and
III collagen but smaller than those of Type IV collagen.
The triple helical region of Type V collagen is also larger
than the triple helicies of Types I, II, and III collagen
(Burgeson et al, 1976).

The configuration of Type V coJla-

gen fibers in the extracellular matrix is not firmly
established.

The fibers appear to interact forming

parallel longitudinal arrays of fibrils similar to those

15

formed by interstital collagens (Bentz et al, 1978).

The thermal stability of the Type V collagen triple
helix appears to be similar to the helicies of other
collagens, all have mid-point melting temperatures (TM)
of 37°C (Rhodes and Miller, 1978).

The Type V collagen

melting curve shows a slight inflection at 33°C-35°C which
suggests the existence of two distinct molecules, one
being less heat stable than other collagenous molecules.
This unstable species may allow catabolism of the molecule by proteases which do not degrade triple helical
collagen but can degrade denatured collagen.

Type V

collagen is degraded by thrombin, trypsin, chymotrypsin
and elastase at temperatures above 34°C (Sage et al, 1981).
At these temperatures the triple helix of Type V collagen
begins to denature making the molecule more susceptible to
degradation.

Mammaliam Collagenase

The catabolism of collagen is initiated by the enzyme
collagenase.

Collagenases are a family of enzymes which

play an important role in tissue remodeling (Mainardi et
al, 1980a) and certain pathological states such as
rheumatoid arthritis (Evanson et al, 1968).

They are
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the only enzymes capable of initiating the breakdown of
mature triple helical collagen (Gross

et al, 1974). Collagen-

ases act by making one break in all threeo( chains in the
triple helical region of the molecule.

The cleavage site

in Type I collagen has been localized to glycine residue
778 and isoleucine residue 779 which occur three quarters
of the distance down the length of the<?\ chains from the
amino terminal end (Gross et al, 1974).

Two digestion

fragments are formed as a result of enzymatic cleavage,
the TCA and TCB fragments.
75% of the

o'\ chain

The TCA fragment represents

and the TCB fragment is 25%.

The pro-

duction of specific reaction products at neutral pH and
temperature which supports a triple helical conformation
......_

of the substrate is one method of identifying a protease
as a true collagenase (Harris and Vater, 1982).

These

specific reaction products were first identified by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) following incubation of Type I collagen with
tadpole tailfin collagenase (Gross and Nagai, 1965).

Following the initial cleavage by collagenase the
collagen triple helix denatures under physiological conditions, the TCA and TCB fragments are not thermally
stable at temperatures above 34°C (Sakai and Gross, 1967).
The denatured molecule is now susceptible to degradation
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by non-specific proteinases (Harper, 1980).

Denatured

collagen fragments are degraded into smaller peptides by
enzymes called gelatinases (Vaes et al, 1978).

Collagenase

isolated from fibroblasts can degrade denatured as well as
native collagen; however, the rate of proteolysis of native
substrate is faster (Welgus et al, 1982).

The study of collagen catabolism has led to the discovery of substrate specific collagenases.

Collagen

Types I, II, and III are degraded by classic or interstitial collagenase (Harper, 1980).

This enzyme does not

degrade Types IV and V collagen (Sage et al, 1979; Liotta
et al, 1981a; Woolley et al, 1978).

Interstitial colla-

genases have been isolated from several cell types including fibroblasts (Bauer et al, 1975), macrophages
(Mainardi et al, 1980a), polymorphonuclear leukocytes
(PMN) (Horwitz, 1977), eosinophils (Hibbs et al, 1982),
bone cells (Puzas and Brand, 1979), rheumatoid synovial
cells (Woolley et al 1975a) and several tumor cell lines
(Wolf et al, 1982; O'Grady et al, 1982; Liotta et al,
1979).

All collagenases studied share several properties

including:

(1) a pH optimum in the range of neutrality;

(2) require Ca 2 + for maximal activity; (3) are inhibited
by ethylenediamine tetracetic acid (EDTA), a metal ion
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chelator and thus are characterized as metalloproteinases;
(4) produce TCA and TCB reaction products under nondenaturing conditions; and (5) they are synthesized in a
latent form requiring activation for maximal activity.

Collagenases which degrade interstitial collagen have
been purified from several sources using a variety of
techniques.

A range of molecular weights from 30,000 to

150,000 daltons have been reported for the different
purified collagenases (Nagai, 1973).

Collagenase in tissue

culture medium or tumor homogenates is usually purified by
ammonium sulfate fractionation followed by ion exchange
chromatography and/or affinity chromatography.

These pro-

cedures are followed by gel filtration chromatography and
~

molecular weight determination on SDS-PAGE.

Collagenase isolated from the medium of cultured
human skin fibroblasts is the best characterized form of
the enzyme.

Fibroblast collagenase appears to have both

cationic and anionic regions, it

bi~ds

to anionic resins

(Woolley et al, 1973), and cationic resins (Stricklin et
al, 1977) at similar pH and salt concentrations.

Fibro-

blasts secrete collagenase in a latent procollagenase form
(Bauer et al, 1975), two different procollagenases with
molecular weights of 60,000 and 55,000 daltons have been
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identified (Stricklin et al, 1977).

Procollagenase does

not bind to collagen substrates, upon activation the
enzyme binds tightly to its substrate (Stricklin et al,
1978).

The two forms of procollagenase can be activated

by limited tryptic digestion to give two active species
of enzyme with molecular weights of 50,000 and 45,000
daltons (Stricklin et al, 1977).

Fibroblast procollagenase

can also be activated by organomercurial compounds, this
reaction proceeds without an initial decrease in enzyme
molecular weight (Stricklin et al, 1983).

Lower molecular

weight species are formed, however, their production is
not coincident with the increase in enzyme activity
(Stricklin et al, 1983).
~sponsible

Autocatalytic cleavage is re-

for the eventual decrease in enzyme molecular

weight (Stricklin et al, 1977).

Collagenases which degrade interstitial collagen have
been purified to homogeneity from several sources.
genase from rabbit

v2

Colla-

ascites cell carcinomas and Walker

256 carcinoma cells have been purified to homogeneity and
molecular weights (MW) of 34,000 and 42,000 daltons,
respectively, were reported
and Wirl, 1982).

(McCroskery et al, 1975; Wolf

Other collagenases which have been

isolated in pure form include human rheumatoid collagenese MW 33,000 daltons (Woolley et al, 1975a), porcine
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synovial collagenase MW 44,000 daltons (Cawston and Tyler,
1979), neutrophil collagenase MW 70,000 daltons (Christner et al, 1982), and guinea pig skin collagenases MW 40, 000
and 130,000 daltons (Huang and Abramson, 1975).

Fiedler-

Nagy et al (1977) have isolated collagenase from human
fibroblast cultures.

They reported a series of peaks of

enzymatic activity following gel filtration chromatography which corresponded to MW of 40,000 to 150,000
daltons.

They found that the enzyme was present in a

tightly bound complex with a hydroxyproline containing
peptide, most likely a fragment of collagen.

Complexes

of collagenase and different sized collagenous fragments
were responsible for the numerous peaks of enzyme activity.
--.

Thes e types of complexes may also account for the differences in MW values reported for different purified
collagenases.

Collagenases which specifically degrade Type IV
collagen have been isolated from human leukocytes (Ditto
et al, 1980) and from the medium of a cultured metastatic
murine sarcoma cell line (Liotta et al, 1979).

Type IV

collagenase from sarcoma cells was later purified (Salo
et al, 1983).

The isolated activity had a MW of 160,000

daltons, if Triton X-100 was added to the preparation and
rechromatographed its MW decreased to 70,000 daltons.
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This indicated the enzyme has hydrophobic properties and
the large molecular weight form may be an aggregate of
enzyme molecules.

SDS-PAGE further separated the activ-

ity into two distinct components with MW of 68,000 and
62,000 daltons.

The Type IV collagenase was secreted in

2
a latent form, required Ca + for activity and produced
specific reaction products.

The degradation of Type IV collagen by PMN elastase
has been reported (Mainardi et al, 1980b).

PMN's also

contain a collagenase which degrades interstitial collagens (Horwitz et al, 1977).

The PMN Type IV collagenase

described by Uitto et al (1980) is different from the
interstitial collagenase, however, it may be an elastase-like protease similar to that reported by Mainardi
et al (1980b).

It has several properties which are

characteristic of elastases including inhibition by phenylmethylsulfonyl floride (PMSF), an inhibitor specific for
serine proteases (Fahrney and Gold, 1963).

Type V collagen specific degrading activities have
been detected in the medium of cultured normal and malignant macrophages (Mainardi et al, 1980a; Liotta et al,
198lb).

Mainardi separated normal macrophage Type I and

Type V collagenases using DEAE cellulose chromatography.
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The Type V collagenase was characterized as a neutral protease inhibited by EDTA but not PMSF.

Liotta et al (1981b)

characterized a Type V collagen degrading activity synthesized by malignant macrophages.

This activity was secreted

in a latent form, was inhibited by EDTA but not PMSF, produced specific reaction products and had a MW of 80,000
daltons as determined by gel filtration chromatography.

Regulation of Collagenase Activity

Collagenases are secreted by most cells in a latent
form, requiring activation for maximal activit y (Bauer et
al, 1975).

The exact nature of latent collagenases has

-..... not been established.

The enzyme may be secrete d as an

enzyme-inhibitor complex (Sellers et al, 1977 ) or in
zymogen form (Stricklin et al, 1977).

Activation of

latent collagenases usually proceeds with a d ec rease in
molecular weight of 10,000 to 20,000 daltons (Stricklin
et al, 1977; Sellers et al, 1977; Wolf and Wirl, 1982).
Limited proteolysis of latent collagenase results in
increased enzymatic activity.

In vitro several proteases

catalyze this activation process, included are trypsin
(Bauer et al, 1975), plasmin (Vaes et al, 1975), mast
cell proteinase (Birkedal-Hansen et al, 1976), endogenous
serine protease (Woessner, 1977), tadpole proteinase
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(Harper et al, 1971), lysozomal protease (Eeckhout and
Vaes, 1977) and metalloproteinases (Horwitz et al, 1976).

Collagenase can be activated in vitro by several nonproteolytic mechanisms.

Incubation of latent enzyme with

chaotropic ions such as I

and SCN-, organomercurial com-

pounds (Stricklin et al, 1983) and disulfide containing
compounds (McCartney et al, 1980) all produce a more active
species of collagenase.

These compounds act by dissociating

enzyme-inhibitor complexes or by disrupting the configuration of the native zymogen enzyme (Stricklin et al, 1983).
These processes are followed by autocatalytic intramolecular activation, and the active enzyme formed is of lower
molecular weight (Bauer et al, 1975; Stricklin et al, 1977).

The production of collagenases is regulated by the
capacity of the cell to synthesize the protein (Valle and
Bauer, 1977) and by the degree to which the cell is stimulated by surrounding cells.

Johnson-Muller et al (1978)

showed that normal epithelial cells stimulate the release
of collagenase from stromal cells via the action of a
soluble factor.

Macrophages and T-lymphocytes also

secrete a soluble factor which stimulates release of
collagenase from synovial cells (Dayer et al, 1979).
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Secretion of collagenases by fibroblasts is increased when
the fibroblasts are cocultured with B-16 melanoma and A-10
adenocarcinoma cells, two epithelial-like tumor cell lines
(Biswas, 1982).

Rat mammary adenocarcinoma cells, also an

epitelial-like tumor cell secrete plasminogen activator CPA).
PA catalyzes the formation of plasmin, this protease can
stimulate collagenase activity in vivo by activating latent
collagenases present in stromal tissues ( 0' Grad_y et al, 1980).
Cell-cell interactions may be important during invasion, such
interactions can result in increased levels of collagen degrading enzymes in the extracellular matrix.

These enzymes

may facilitate the breakdown of connective tissue barriers
encountered by invading tumor cells.

Collagenase Inhibitors

Collagenases are inhibited by both tissue specific
inhibitors and by several components of serum.

Normal

serum has been fractionated by isoelectric focusing and
three inhibitory zones have been identified according to
They are the'7( , ~ ,

their electrophoretic mobility.
and

0

zones (Broth et al, 1981).

component of serum, found in the
globulin.

c;;:{ 2

The major inhibitory

~-zone is o( 2 macro-

macroglobulin is a non-specific inhibitor of

most endopeptidases (Seifter et al, 1970).

Also present

in this fraction are antithrombim III and ~l anti trypsin,
the latter has only minor collagenase inhibitory
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capacity (Woolley et al, 1975b).
serum, the
named

,f>

1

The second fraction of

~ -zone contains a low molecular weight protein
- anticollagenase which specifically inhibits

collagenase but not other proteases (Woolley et al, 1976).
The

~ electrophoretic zone of serum contains a cationic

protein which inhibits collagenase.

This protein may be

the Clq component of complement which has a collagen-like
structure.

It inhibits collagenase by acting as a com-

petitive substrate (Nagai et al, 1978).

Several tissue specific collagenase inhibitors have
been identified.

Keuttner et al (1976) characterized a

low molecular weight (11,000 daltons) cationic protein
from bovine aorta and cartilage which inhibit e d colla-

-....

genases under physiological conditions.

Two groups have

isolated and characterized a 28,000 dalton protein from
amniotic

fluid which inhibits collagenolytic activity

(Murphy et al, 1981a; Aggeler et al, 1981).

Additional

tissue specific collagenase inhibitors have been isolated
from human synovium (Murphy et al, 198lb), rabbit bone
cells in culture (Cawston et al, 1981), cultured human
skin fibroblasts (Welgus et al, 1979), and porcine gingival
explants (Pettigrew et al, 1981).
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Elastin

Elastin is a structural protein found in the extracellular matracies of several tissues including lung, skin,
blood vessels, cartilage, and breast (Werb et al, 1982).
Elastin provides these tissues with tensile strength and
elasticity (Anwar et al, 1977).

Alterations in elastin

metabolism are associated with several disease states
(Sandberg et al, 1981).

Desmoplasia, the excessive deposi-

tion of stromal connective tissue is often associated with
the growth of invasive breast carcinomas (Barsky et al,
1982).

Accumulation of newly synthesized elastin is a

common feature associated with the desmoplastic response
...__

(Lundmark, 1972) .

The primary structure of elastin is unique in that it
contains large quantities of non-polar amino acids (Keeley
et al, 1974).

Tropoelastin, the subunit of mature elastin

contains 11 repeating sequences of the pentapeptide val-progly-val-gly, a second hexapeptide pro-gly-val-gly-val-ala
found in a trypsin-sensitive region of tropoelastin repeats
itself 6 times (Foster et al, 1973).

Tropoelastin also has

a high lysine content, these residues are present in pairs
separated by 1 to 3 alanine residues and preceded by 1 to 8
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alanine residues (Sandberg et al, 1972).

Tropoelastin

subunits are crosslinked to form elastin following the
oxidative deamination of specific lysine residues by the
enzyme lysyl oxidase (Pinell and Martin, 1968).

The

enzymatically formed reactive aldehyde groups of adjacent
subunits spontaneously react to form covalent bonds.

The

crosslinking residues desmosine and isodesmosine are
formed when three deaminated lysine residues and one
epsilon amino group of a fourth

lysine from tropoelastin

monomers are joined (Lent et al, 1969).

Crosslinks

stabilize the protein and make it resistant to proteolysis (Stone et al, 1982).

Elastin fibers in the extra-

cellular matrix consist of two components:
~f ibrillar

(1) a micro-

component which is very susceptible to degrada-

tion and (2) an amorphous component which is resistant to
proteolysis (Werb et al, 1982).

Elastase

Mature elastin is degraded by several enzymes known
as elastases.
the

Elastolytic activity has been detected in

~-cells of the pancreas (Marshall et al, 1969),

PMN's (Ohlsson and Olsson, 1974), macrophages (Banda and
Werb, 1981), platelets (Hornebeck et al, 1980), smooth
muscle cells and fibroblasts (Boudillon et al, 1980),
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human breast carcinoma cells (Kao et al, 1982) and metastatic human tumor cells (Jones and DeClerck, 1980).
These elastolytic activities cleave the elastin molecule
in different sites, are inhibited by different compounds,
and have different cellular locations.

Elastin has

multiple cleavage sites and is degraded to several low
molecular weight peptides by elastases (Werb et al, 1982).
The cleavage site for pancreatic, macrophage, and PMN
elastases have been identified.

Pancreatic elastase

cleaves peptide bonds in elastin which are carboxyl to
glycine, valine and alanine residues (Barrett et al, 1980).
This elastase is inhibited by PMSF and classified as a
serine protease (Fahrney and Gold, 1963).
-.....

Macrophage

elastase only cleaves peptide bonds on the amino side of
leucine residues (Banda and Werb, 1981).

Macrophage

elastase is characterized as a metal-dependent proteinase,
its activity is blocked by EDTA (White et al, 1980).
Elastase from PMN's cleaves elastin at sites which are
carboxyl to alanine and valine residues (Barrett et al,
1980).

This enzyme is inhibited by PMSF and is a serine

protease.

Fibroblast elastase has been characterized as

a metal-dependent protease (Bourdillon et al, 1980).

The

elastolytic activity associated with cultured human breast
carcinoma cells is inhibited by both EDTA and PMSF, these
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cells may contain more than one protease which degrades
elastin substrates (Kao et al, 1982).

Pancreatic elastase is secreted from the -.E3-cells in
an inactive form and is activated by trypsin in the
intestine (Barrett et al, 1980).

PMN elastase has been

localized inside the cell in azurophil granules (Werb et
al, 1982).

Elastase from macrophages and human breast

carcinoma cells is found in the medium when these cells
are maintained in culture (Banda and Werb, 1981; Kao et al,
1982).

The elastolytic activity of metastatic human tumor

cells was not detected in the medium or inside the cells
and was present only when the cells were attached to a
suitable substrate (Jones and DeClerk, 1980).

---

Smooth

muscle cell and fibroblast elastases are not secreted into
the growth medium but these activities can be extracted fran
cell sonicates using Triton X-100, suggesting they are membrane bound (Hornebeck et al, 1980).

Elastase Inhibitors

The activity of elastases are limited by the presence
of several natural inhibitors (Werb et al, 1982).

The two

major elastase inhibitors are found in the serum, they are
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cA

1

antitrypsin and

1974).

°'

2 macroglobulin (Ohlsson and Olsson,

Pancreatic and PMN elastases are more susceptible

to inhibition by

c)\

1

antitrypsin than ~

2

macroglobulin.

Macrophage elastase is primarily inhibited by
globulin.

c::\ 2

Macrophage elastase also inactivates

~

macro1

anti-

trypsin by degrading it, freeing other bound inactivated
elastases (Banda et al, 1980).

Imbalances in the ratio of

elastases to inhibitors where elastases arein excess are
thought to be involved in disease states such as chronic
obstructive pulmonary disease (Eriksson, 1979), rheumatoid
arthritis (Cox and Huber, 1976), and emphysema (Stone et
al, 1982).
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EXPERIMENTAL

Materials

All reagents used in this study were of analytical
grade.

3
Reagents used included [ H]-sodium borohydride,

3
specific activity 100 mCi/mmol, [2- H]-glycine, specific
activity 44 Ci/mmol, [1-

14

c]-acetic anhydride, specific

activity 10 mCi/mmol and Atomlight liquid scintilation
fluid, purchased from New England Nuclear Corporation.
Trypsin, 2X crystallized was purchased from Worthington
Biochemical Corporation.

Soybean trypsin inhibitor type

II-S, pepsin, 2X crystallized and bacterial collagenase
Type VII were from Sigma Chemical Company.

Acrylamide,

N', N'-methylene bisacrylamide, sodium dodecyl sulfate,
N, N, N, N tetramethylenediamine, ammonium preoxysulfate
and CoomassieBrilliant Blue were obtained from Eastman
Kodak.

Ultrogel AcA44 was purchased from LKB and

diethylaminoethyl cellulose (DE-52) was from Whatman.
All tissue culture reagents were obtained from Grand
Island Biological Company.

Cell Culture

The cell lines used in this study were obtained from
the Roger Williams General Hospital Cancer Center and
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included:

DLD-1 a human colon carcinoma (Dexter et al, 1979),

Bl6-Fl0 a murine melanoma (Fidler, 1973), and normal human
dermal fibroblasts.

DLD-1 cells were grown in RPMI 1640

medium supplemented with 10/. heat inactivated fetal calf
serum (FCS), 100 U penicillin/ml, 100 µg streptomycin/ml,
2.5 µg Fungizone/ml, 20 µg gentamycin/ml, 60 µg Tylocine/ml
and buffered with 0.075% NaHC0 , 10 µM Hepes and 10 µM Tri3
cine.

Fibroblasts were grown in Dulbecco's Modified Eagle

(DME) medium

supple~ented

with 10% FCS, 3.5 mg glucose/ml,

100 U pencillin/ml and 100 µg streptomycin/ml.

B16-F10

cells were grown in Minimum Essential Medium supplemented
with 10% FCS, 100 U pencillin/ml, 100 µg streptomycin/ml,
2.5 µg Fungizone/ml, 200 µg gentamycin/ml, 20 mM gultamine,
~1

mM non-essential amino acids, 1 mM sodium pyruvate and

buttered with 0.1% NaHC0

3

and 2 µM Hepes.

Cells were maintained in a humidified environment at
37°C containing 5%

co 2

and 95% air in 100 x 20 mm tissue

culture dishes (Falcon 3003).

Confluent monolayers were

subcultured by removing the medium by suction, washing the
cell layer with isotonic phosphate buffered saline (PBS) pH
7.0 and incubating the cultures in PBS which contained 0.25%
trypsin, 0.2 mg glucose/ml and 0.2 mg EDTA/ml.

Detached

cells were centrifuged for 5 minutes at 500 Xg and
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resuspended in fresh medium.

Each dish of cells was re-

plated into four 100 x 20 mm tissue culture dishes.

Preparation of Culture Media for Enzyme Assays

Media from cell cultures were assayed for Types I and
V collagen degrading activities and elastase activity.

The

secreted enzymes were precipitated and concentrated by ammonium sulfate fractionation using the method of Liotta et al
(1981).

The medium of late log phase cultures was decanted

and the cell layers were washed three times with PBS.

Fresh

serum-free media (10 mls/100 x 20 mm plate) was added and
cultures were incubated for 24 hours.

The medium from three

100 x 20 mm plates was pooled and centrifuged for 5 minutes
at 900 Xg to remove cells and debris.

Medium proteins were

precipiated by addition of crystalline ammonium sulfate to
60% of saturation and centrigured for 60 minutes at 27,000
Xg at 4°C.

Precipitates were resuspended in 2 ml of 0.05M

Tris-HCl pH 7.5 containing O.OlM CaC1 2 and dialyzed against
10 liters of this buffer for at least 16 hours at 4°C.

Ali-

quots of the dialysate were activated by incubation with
trypsin (10

~g/ml)

at a 4:1 dialysate to trypsin ratio for

5 minutes at 37°C.

The reaction was halted by addition of

a five molar excess of soybean trypsin inhibitor, samples
were cooled to 4°C, and then assayed for enzymatic activity.
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Preparation of Cells for Elastase, Protein and DNA Assays

Cell layers were harvested by incubation with PBS containing 1 mM EDTA at 37°C.

Detached cells were collected

and washed three times with 0.05M Tris-HCl pH 7.5 containing
0.9/. NaCl and 0.01 M CaC1 .
2

The cells were resuspended in

1 ml of idalysis buffer which contained 0.1/. Triton X-100
and sonicated three times for 10 seconds at 50 watts.

Ali-

quots of the sonicate were used for elastase assays and
determination of protein and DNA content.

Dirnethylformamide (DMF) Treatment

DMF was added to RPMI culture medium to give a final
concentration of 0.8/. (V/V).

DLD-1 colon carcinama cells

were grown in this media and only cells which had been subcultured 3-5 times were used.

This dose of DMF is not

toxic to this cell line and the cells displayed the morphologic changes described by Dexter et al (1979) after
3 passages.

Measurement of Protein Synthesis

The effect of DMF treatment on the capacity of DLD-1
colon carcinoma cells to synthesize and secrete protein was
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studied by measuring the incorporation of

3

H-glycine into

trichloracetic acid (TCA) precipitable cellular and media
protein.

Control and DMF treated DLD-1 cells were plated

into 100 x 20 mm culture dishes at a density of 1 x 10 6
cells/plate in 10 ml of media.

The experiments were per-

formed when the cultures were in the late log phase of
growth.

The medium was removed and replaced with 10 ml

of fresh medium supplemented with 1% FCS and 5 µCi/ml
2- 3H-glycine.

Incorporation of

3

H-glycine into protein

was measured after 3 and 6 hours of incubation.

At these

times the media were collected and the cells were immediately
washed 3 times with PBS containing 5 µg cycloheximide/ml.
The cells were detached with 0.25% trypsin-PBS, counted and
--. sonicated in PBS containing 5 µg cycloheximide/ml 3 times

for 10 seconds at 50 watts.

Medium and cell proteins were

precipiated by addition of ice cold TCA to a final concentration of 10%.

Protein precipitates were washed three

times with 5 ml of ice cold 10% TCA then hydrolyzed in 1 ml
of Digestol (Yorktown Research) for 3 hours at 60°C.

The

hydrosylates were mixed with 10 ml of Econofluor liquid
scintilation fluid and the radioactivity determined.

Ali-

quots of the cell sonicates were removed prior to precipitation and used for protein and DNA determinations.
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Protein Determination

All cell and medium enzyme values in this study were
normalized using total intracellular protein values.

Pro-

tein content was determined by the method of Lowry et al
(1951); bovine serum albumin was used as a standard.

An

aliquot of 0.01 ml of the cell sonicate was used in each
determination.

DNA Determination

The DNA content of cell mornoayers was determined using
the fluorometric assay of Prasad et al (1972).
thymus DNA was used as a standard.

Bovine

In a typical assay 0.1

ml of cell sonicate was diluted with 0.4 mls of PBS.
Ethidium bromide (10 µg) was added to each assay, this compound intercalates nucleic acids making them fluorscent.
Any RNA present was digested by addition of 200 µg of
ribonuclease.

Fluorescence was measured at an excitation

wavelength of 360 nm and an emission wavelength of 590 nm.
The fluorescence observed before addition of ribonuclease
minus that observed after its addition was used to calculate the a.mount of DNA present.

The decrease in fluore-

scence following ribonuclease treatment represents the
RNA content.
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Purification of Collagens

Type I collagen previously purified in this laboratory
by the method of Fuji and Kuhn (1975) was labeled with 14cacetic anhydride and used as a Type I collagenase substrate.
Type V collagen was purified by the method of Rhodes and
Miller (1978).

Human placentas were collected and stored

forzen at -20°C until sufficient quantities were accumulated.
Placentas were thawed, the amnionic membranes were removed
and used in subsequent steps.
were carried out at 4°C.

All of the following procedures

The membranes were extracted for 2

days in 0.9% NaCl and for 2 days in 0.5 M acetic acid, both
extractions were performed in the presence of protease in~ hi bi tors.

The purification procedure is outlined in Figure 1.

Amnions were minced and centrfuged and the wet weight was
determined.

The minced tissues were suspended in 0.5 M ace-

tic acid at a ratio of 20 grams wet tissue/100 ml of acetic
acid.

Pepsin, 1500 units/ml, was added to the suspension,

stirred for 24 hours then centrifuged for 45 minutes at
30,000 Xg.

The supernatant fluid was collected and crystal-

line NaCl was added to a final concentration of 0.8 M.

The

solution was stirred for 24 hours, then centrifuged for 45
minutes at 30,000 Xg, and the pellet was discarded.

The

supernatant NaCl concentration was increased to 1.2 M by
the addition of crystalline NaCl, and the solution was
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CLARIFIED PEPSIN DIGEST
Add NaCl to O.BM

Precipitate

SUPERNATE
Add NaCl to l.2M

PRECIPITATE

Supernate

Dissolve in 1. Oili NaCl pH 7. 4
Add NaCl 4.5M

PRECIPITATE
Supernate
Dissolve in O.lM Acetic Acid
Add NaCl to 1.2M

Supernate
Dissolve in O~lM NaCl pH 7.4
Dialyze vs. 0.02M NaCl
2.0M Urea pH 8.6

PRECIPITATE
TYPE V COLLAGEN

Figure 1:

Supernate

DIAGRAM OF THE PURIFICATION PaOCEDURE USED TO
ISOLATE TYPE V COLLAGEN. Type V collagen was
purified from amnionic pepsin digests by the
outlined procedure.
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stirred for 24 hours.

The precipitate which formed was col-

lected by centrifugation and resuspended in 0.05 M Tris-HCl
pH 7.4 containing 1 M NaCl.

The Type V collagen in this

solution was precipitated by adjusting the NaCl concentration
to 4.5 M.

The precipiate collected by centrifugation was

dissolved in 0.1 M acetic acid and the collagen was reprecipitated by adding NaCl to 1.2 M.

The precipitate formed

was collected and resuspended in 0.05 M Tris-HCl pH 7.4
containing 0.1 M NaCl and was dialyzed against 0.01 M TrisHCl pH 8.6 containing 0.02 M NaCl and 2 M urea.

The pre-

cipitate formed during dialysis was collected and dialyzed
against 0.05M acetic acid and lyophilized.

Aliquots of eaeh

purification step were analyzed by SDS-PAGE by the method
of Neville (1971) using 6% polyacrylamide slab gels.

14 c-Acetylation of Types I and V Collegens

Types I and V collagens were labeled with
anhydride.

14

c-acetic

The labeling procedure utilizes an acetylation

reaction which adds a

14

c-acetate group to the epsilon

amino groups of lysine residues in the triple helical
region of the collagen molecule (Gisslow and McBride 1975).
Purified collagen was suspended in 0.01% acetic acid at a
concentration of 2 mg/ml; a typical reaction employed a
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total of 200-300 mg of collagen.

Prior to addition of the

acetylating agent, the pH of the collagen solution was adjusted to 8 by the slow addition of 1 M K HP0 .
2
4

1- 14 c-acetic

anhydride, 1 mCi in 1.5 ml of benzene, was added dropwise
over the course of 2 hours, the pH was maintained at 8 during
the course of the reaction by addition of 1N NaOH.

After

this time the solution was acidified with glacial acetic
acid to pH 4, dialyzed exhaustively against deionized water
and lyophilized.

A 2 mg sample of the dried protein was

hydrolyzed in 0.5 mls of Digestol at 60°C for 3 hours and
the specific activity of the substrate was determine.

Ace-

tylation of Type I collagen yielded a substrate with a
specific activity of 1.41 x 10

6

dpm/mg; the Type V sub-

~strate had a specific activity of 1.12 x 10 6 dpm/mg.

All

substrates were stored at -20°C.

Type I Collagenase Assay

Type I collagenase activity was measured according to
Lindblad and Fuller (1982).

Lyophilized

14

C-labeled Type I

collagen was suspended in 0.01% acetic acid at a concentration of 2 mg/ml.

Immediately prior to use, this solution

was diluted with 0.1 M Tris-HCl pH 7.6 containing 0.4 M
NaCl and 0.01 M Cac1

2

so that 0.05 ml contained approxi-

mately 20,000 counts per minute (cpm).

In a typical assay,
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0.2 ml of activated culture medium was mixed with 0.1 ml of
0.05 M Tris-HCl pH 7.5 containing 0.005 M CaC1 .
2

Each

assay contained 0.05 ml of the diluted substrate solution
and was incubated at 35°C for 1 hour.

The assay was termin-

ated by addition of 0.1 ml of 0.1 M EDTA containing 150 µg
of carrier Type I collagen.

This mixture was incubated for

an additional 30 minutes to assure complete denaturation of
degraded substrate, and then cooled to 15°C for 5 minutes.
Native substrate was precipitated by the addition of 0.8 ml
of a 4:1 (V/V) dioxane/methanol solution.

This mixture was

centrifuged for 25 minutes at 6000 Xg and 0.8 ml of the
supernatant was mixed with 5 ml of Atomlight to determine
soluble radioactivity.

Preparation of a Type V Collagen Degrading Activit y

Type V collagen degrading activity was obtained from
in vivo activated alveolar macrophages maintained in culture using the method of Mainardi et al (1980a).

An adult

female albino rabbit (3 kg) was injected with 0.2 ml of
Freunds complete adjuvant in the ear vein.

Two weeks later

the rabbit was anesthetized and its lungs were surgically
removed.

Alveolar macrophages were washed out of the lungs

by lavage using sterile PBS, the lavage treatment was repeated eight times using a total of 200 ml of PBS.

The
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collected cells were washed three times in DME media containing 100 U penicillin/ml and 100 µg streptomycin/ml.
Cells were plates out in 100 x 20 mm culture dishes at
densities of 1 x 10

7

cells/dish in 10 ml of DME media supple-

mented with 10% FCS, 100 U penicillin/ml, 100 µg streptomycin/
ml and 2.5 µg Fungizone/ml.

Cells which adhered to the plates

after 24 hours of growth in serum containing medium were used
for the remainder of the procedure.

Plates were maintained

at 37°C in a humidified environment containing 5%
air.

co 2

and 95%

Each plate contained 10 ml of serum-free DME media

which was collected and replaced with fresh media every 2
days for 2 weeks.

The collected media was concentrated to

10 ml by pressure dialysis using an Amicon PM-10 ultrafiltration membrane.

A

0.05 ml aliquot of this preparation

degraded approximately 4 µg of Type V collagen substrate in
5 hours at 30°C pH 7.5.

Type V Collagenase Assay

Type V collagen degrading activity was measured using
an improved assay which utilized a soluble substrate, nondenaturing conditions, and dioxane/methanol which precipitates native substrate molecules.

Lyophilized

14

c-

labeled Type V collagen was suspended in 0.01% acetic
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acid at a concentration of 1 mg/ml.

Immediately prior to

use, this solution was diluted with 0.1 M Tris-HCl pH 7.6
containing 0.2 M NaCl and 0.01 M CaC1

2

tained 20,000 cpms (20 µg substrate).

so that 0.05 ml conActivated culture

medium or other enzyme solutions were mixed with 0.05 M
Tris-HCl pH 7.5 containing 0.005 M CaC1
volume of 0.3 ml.

2

in a final reaction

A volume of 0.05 ml of the diluted sub-

strate solution was added to each assay tube and incubated
at 30°C for 12-24 hours.

The assay was terminated by cooling

the samples to 15°C for 5 minutes and adding 0.1 ml of ice
cold dioxane/methanol (4:1 V/V).

Precipitated native sub-

strate was separated from degraded substrate by centrifugation at 6000 Xg for 25 minutes at 4°C.
~the

A 0.2 ml aliquot of

supernatant was mixed with 5 ml of Atomlight to deter-

mine soluble radioactivity.

Elastase Assay

Insoluble elastin powder, purchased from Sigma Chemical
Company, was labeled using

3

H-sodium borohydride by the

method of Stone et al (1982).

The lyophilized labeled

elastin was suspended in 0.05 M Tris-HCl pH 7.5 containing
0.005 M CaC1

2

at a concentration of 1 mg/ml; 0.25 ml of

this suspension was added to 1 ml microcentrifuge tubes.
Aliquots of the cell sonicates (0.1 to 0.5 ml) and 0.05
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M Tris-HCl pH 7.5 containing 0.005 M CaC1

were added to the

2

microcentrifuge tubes in a final reaction volume of 1.0 ml.
The reaction mixtures were incubated at 37°C for 24 hours
without agitation, cooled on ice, and centrfuged in a Fischer
Model 59 microcentrifuge for 2 minutes at 7000 Xg.

A 0.2 ml

aliquot of the supernatant was removed and mixed with 5 ml
of Atomlight to determine soluble radioactivity.

Ion Exchange Chromatography

DEAE cellulose ion exchange chromatography was utilized
to separate Types I and V collagen degrading activities
secreted by DLD-1 colon carcinoma cells.
........

DEAE cellulose

(Whatman DE-52) was suspended in 0.05 M Tris-HCl pH 8.3
containing 0.005 M CaC1

2

and 0.02% NaN , packed into a
3

column 1.6 x 13 cm and allowed to equilibrate at 4°C by
washing with several volumes of buffer.

Pooled serum-free

media from 900 100 x 20 mm culture dishes of late log phase
DLD-1 cells were concentrated by pressure dialysis using
an Amicon PM-10 ultrafiltration membrane and dialyzed
against 10 liters of column buffer.

The sample, approxi-

mately 100 ml, was trypsin activated as previously described and centrifuged for 10 minutes at 8000 Xg to
remove any precipitate which had formed during concentration and dialysis.

The supernatant was then applied to
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the column at a flow rate of 25

ml/hour and the column

was washed with buffer until absorbance at 280 nm of the
effluent returned to baseline.

Bound proteins were

eluted in a linear gradient from 0.0 to 1.0 M NaCl in
column buffer.

The gradient was run over the course of

16 hours using an Ultrograd Gradient Mixer (LKB Bromma,
Sweden). 'Ihe total gradient volume was 480 mls.

Six ml

fractions were collected and monitored for absorbance at
280 nm and assayed for Type I and V collagenase activity.

Gel Filtration Chromatography

Molecular weights of Type I and V collagenolytic
~activities

were determined using Ultrogel AcA44 gel

filtration medium.

The column material was packed into

a column 1.6 x 90 cm at 4°C and equilibrated in 0.05 M
Tris-HCl pH 7.6 containing 0.01 M CaC1 2 and 0.02% NaN .
3
The flow rate of the column was kept constant at 8 ml/
hour.

The column was calibrated using the globular

protein standards bovine serum albumin, ovalbumin,
carbonic anhydrase and ribonuclease, 1 mg of each
standard was chromatographed separately.

Blue Dextran

2000 was used to determine the void volume (V ).
o

tions of 2 ml

Frac-

were collected and the absorbance at 280

run was monitored.

Peaks of Type I or TypP V collagenolytic

activity from the DE-52 chromatogram were concentrated to
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1 ml by pressure dialysis using an Amicon PM-10 ultrafiltration membrane.
column.

These samples were applied to the

Fractions of 2 ml were collected, the absorbance

monitored at 280 nm was monitored, . and the fractions were
assayed for Ty..pes I and V collagenase activity.

Statistical Analysis

The statistical methods used in this study were
obtained from the statistics textbook, "Introduction to
Applied Statistics", (Lentner, M., 1976).

1.

Mean (X) =

EX.l /n

n

= sample size

X.l = ith sample value

~

2.

Standard Deviation( s)

3.

Unpaired Student t test

2
Exi - X) I (n - 1 )!

= t =

(Xl

[i:
n

= sample size of 1 group

degrees of freedom

= 2(n-1)

x2)

8 ~1;2

I
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RESULTS

Purification of Type V Collagen

Collagenous proteins present in an insoluble form in
the extracellular matracies of many tissues can be
extracted in a soluble form by limited digestion of the
tissue with pepsin.

This procedure was employed to

solubilize Type V collagen from human amnionic membranes.
Pepsin soluble collagens can be separated by differential
precipitation with NaCl.

This procedure takes advantage of

solubility differences between the five genetically distinct collagen types.
~III

Interstitial collagen Types I and

in the amnionic pepsin digest were precipitated at

low ionic strength (0.8M NaCl). Type V collagen precipitated when the ionic strength of the solution was
raised to 1.2M NaCl.

This precipitate was suspended in

neutral salt buffer to inactivate any residual pepsin
and the Type V collagen was reprecipitated by the addition
of NaCl to 4.5 M.

The 4.5 M NaCl precipitate was suspended

in neutral salt buffer and dialyzed against a buffer of
low ionic strength.

This step separates Type V collagen

from low molecular weight protein fragments which are
soluble in low ionic strength solutions.
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The precipitate formed during dialysis contained
purified Type V collagen.

The purification began with

745 grams of amnionic membranes (wet weight) and produced 350 mg of Type V collagen, a yield of 0.05%.

The

purity of the preparation was monitored by SDS-PAGE at
various stages of the purification as shown in Figure 2.
The electrophoretic pattern of purified Type I collagen
is shown for comparison (Lane 1).

The whole pepsin

digest was found to contain both interstitial and Type V
collagens (Lane 2).

The precipitate which formed at

0.8M NaCl contained predominately Type I collagen and
was devoid of Type V collagen (Lane 3).

Pepsin added

at the start of the purification was separated from
~ Type

V collagen when the NaCl concentration was raised

to 1.2M.

Type V collagen precipitates at this ionic

strength and the pepsin remains soluble (Lane 5).

The

Type V collagen which was purified by pepsin digestion
and differential NaCl precipitation consisted of two~
chains,o\ l(V) and<1'\2(V) present in an approximate 2:1
ratio (Lane 7).

The molecular weights of these J\chains

were estimated to be 117,000 and 105,500 using molecular
weight standards (Lane 8).
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SOS Polyacrylamlde Slab Gel Electrophoresis of Type V Collagen
Purtflcatlon. Aliquots of different stages of the purtflcatton
were electrophoresed and protein bands were vleuallzed by
stalnlng wtth Coomatsee Orllltant Olue.
(1) Purlfled Type I
collagen standard, (2) amntonlc pepeln digest, (3) 0.8M NaCl
prectpltate, (4) pepsin ~tandard, ' (5) 1.2M NaCl supernate,
(6) 4.5M NaCl precipitate, (7) Isolated Type V colla~en,
(8) molecular weight standards.
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Type V Collagenase Assay

An assay for measuring Type V collagen degrading
activity was developed.
labeled with

14

Purified Type V collagen was

c-acetic anhydride. This compound acetylates

the epsilon amino groups of lysine residues in collagen.
The labeled Type V collagen had a specific activity of
1.12 x 10

6

dpm/mg.

The assay was performed at an incuba-

tion temperature of 30°C. This is several degrees below
the point at which the Type V collagen

triple helix

begins to denature (Rhodes and Miller, 1978).

The pre-

cipitating solvent dioxane/methanol (4:1, v/v) was used
to separate native substrate molecules from degraded substrate molecules.

This solvent has been used previously

in Type I collagenase assays (Lindblad and Fuller, 1982).

The solubility of native and denatured Type V collagen
substrate in dioxane/methanol was determined.

Increasing

volumes of the precipitating solvent were added to native
substrate (30°C) and substrate which had been denatured by
heating at 60°C for 30 minutes.

The solutions were

centrifuged and the amount of substrate which precipitated
was determined (Figure 3).

Native substrate molecules

precipitated at much lower dioxane/methanol concentration
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I

Solubility of Native and Denatured Radiolabeled
Type V Collagen in Dioxane/Methanol/Water.
Increasing volumes of a dioxane/methanol
solution (4:1, v/v) were added to native (30°C)
and heat denatured (60°C for 30 mi n s.)
14c-Type V collagen, centrifuged and soluble
radioactivity was determined.
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than denatured substrate molecules.

The difference in

their solubilities was greatest between 23%-46 % dioxane/
methanol.

The solubility of enzymatically produced Type V
collagen reaction products in dioxane/methanol were
determined.

Native substrate was degraded by three

different collagenases, Clostridium histolytium collagenase.

(E.C. 3.4.24.3), rabbit alveolar macrophage

collagenase, and collagenase obtained from the media
of cultured DLD-1 colon carcinoma cells.

The enzyme-

substrate solutions were incubated at 30°C for six hours
then increasing volumes of dioxane/methanol were added.
-....._

Following centriguration, the solubility of the reaction
products were determined (Figure 4).

When the substrate

was degraded by bacterial collagenase soluble radioactivity was highest at 29% dioxane/methanol.

Following

incubation with alveolar macrophage and DLD-1 collagenases
soluble radioactivity was highest at 13% dioxane/methanol.
To optimize the detection of enzyme activity while precipitating the majority of the native substrate molecules
23% dioxane/methanol was chosen as the standard concentration to be used in the assay.

At this concentration

70% of the native substrate is precipitated and appreci-
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Figure 4.

Solubility of Radiolabeled Type V Collagen
Degradation Products Formed by Three Collagenases
in Dioxane/Methanol/Water.
1 4 c-Type V collagen
(20 µg) was incubated with three different
collagenases; bacterial collagenase, alveolar
macrophage collagenase and DLD-1 colon carcinoma
collagenase at 30°C.
Increasing volumes of
dioxane/methanol · (4:1, v/v) were added, centrifuged and soluble radioactivity was determined.
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able amounts of enzymatic activity can be detected.

As shown on Figure 5,degradation of the substrate by
alveolar macrophage collagenase was linear with time.
Approximately 20% of the added substrate (20 µg) had been
degraded after five hours of incubation at 30°C and pH 7.5.

Levels of Collagenolytic and Elastinolytic Activities
In Normal Fibroblasts, DLD-1, and B16-F10 Cells

Late log phase cultures of DLD-1 colon carcinoma
cells, B16-F10 murine melanoma cells, and normal dermal
fibroblasts were maintained in serum-free media for 24
hours.

The cells and media were processed for enzyme

assays, protein and DNA determinations as described in
the Experimental Section.

DLD-1 cells and normal fibro-

blasts produced comparable levels of Type I collagenolytic
activity (Table 1).

B16-Fl0 cells produced approximately

half as much activity.

Normal fibroblasts produced the

highest level of Type V collagenolytic activity (0.48 ±
0.14 µg collagen degraded/mg protein/hr), DLD-1 cells
produced about half this amount of activity while Bl6-Fl0
cells only degraded 0.13 ± 0.06 µg collagen/mg protein/hr.
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Degradation of Radiolabeled Type V Collagen
by Alveolar Macrophage Collagenase As A
Function of Time.
14c-Type V collagen (20 µg)
was incubated with alveolar macrophage collagenase
at 30°C for various lenghts of time and the amount
of substrate degraded was determined.

Table 1.

Levels of Type I Collagenase,~Type V Collagenase, Cellular Elastace, and
Media Elastase Produced by DLD-1 Colon Carcinoma Cells, B16-F10 Melanoma
Cells, and Normal Dermal Fibroblasts.

ENZYME ACTIVITY
µg substrate degraded/hr/mg protein
CELL LINE

TYPE I
COLLAGENASE

TYPE V
COLLAGEN ASE

DLD-1 Colon
Carcinoma

7 .18 ± 0 .80

0.25 ± 0.03

0.25 ± 0.04

31.97 ± 2.80

B16-F10
Melanoma

3.70 ± 0.26

0.13 ± 0.06

0.38 ± 0.09

0.55 ± 0.09

Normal Dermal
Fibroblast

7.27 ± 1.66

0.48 ± 0.14

0.77 ± 0.26

1.17 ± 0.32

CELLULAR
ELASTASE

Results are expressed as the mean ± S.D. with an n

MEDIA
ELASTASE

= 4.

C.11

(j)
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The Triton X-100 cell extracts and culture media from
the three cell lines were assayed for elastin degrading
activity.

DLD-1 cells produced the highest levels of

elastinolytic activity of the three cell lines, this
activity was found predominately in the media (>99% of the
total).

Fibroblasts contained the second highest level of

elastinolytic activity, approximately 40% of the activity
was cell-associated and 60% was in the media.

The elastin

degrading activity from Bl6-F10 cells was distributed
between the cellular compartment and the media in the same
ratio as the fibroblast activity.

DEAE Ion Exchange Chromatography

Media containing DLD-1 collagen degrading activities
was collected and several attempts were made to separate
Type I and Type V collagen degrading activities using gel
filtration chromatography.

These attempts proved to be

unsuccessful, each chromatogram revealed numerous peaks
of Type I and Type V collagen degrading activity and
adequate resolution of the two activities was not possible.

DEAE cellulose ion exchange chromatography was then

employed to separate Type I and Type V collagen degrading
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activities.

DEAE cellulose chromatography was used to

separate these two activities produced by cultured macrophages (Mainardi et al, 1980a).

Serum-free media from 900

plates of late log phase DLD-1 co-on carcinoma cells
was used as the source of collagenase activity.

As seen

in Figure 6 approximately half of the media proteins bound
to the DE-52 column and half passed through the column.
The fractions containing the protein which did not bind to
the resin were analyzed and only Type V collagen degrading
activity was detected.

The proteins which bound to the

resin were eluted with a 400 ml linear NaCl gradient
(0-0.3M).

This was found to be insufficient to elute all

the proteins, a second gradient of 0.3M to 1.0M NaCl was
used to elute the remainder of the proteins.

The first

peak of protein eluted between 0.2M and 0.3M NaCl, these
fractions were found to contain only Type I collagen
degrading activity.

The proteins which eluted in the

second gradient between 0.3M and 0.5M NaCl were analyzed
for collagenase activity and both Type I and Type V
collagen degrading activity were detected.

Gel Filtration Chromatography

The three peaks of collagen degrading activity generated by DEAE cellulose chromatography were further
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Figure 6.

DEAE Cellulose Chromatography of Concentrated
DLD-1 Colon Carcinoma Cell Serum-Free Media.
Serum-free media from 900 100 x 20 mm culture
dishes of late log phase DLD-1 cells was concentrated and applied to a 1.5 x 13 cm column
of DE-52 equilibrated in 0.05M Tris~Cl pH 8.3
containing 0.005M CaCl2 and 0.02 % NaN 3 . The
bound proteins were eluted in two NaCl gradients, one from 0 to 0.3M NaCl and the second
gradient from 0.3M to 1.0M. Six ml fractions
were collected and monitored for absorbance at
280 nm (Panel B) and analyzed for Type I and
Type V collagen degrading activity (Panel A).
The fractions were combined to form three pools
according to enzyme activity (I, II, III) as
indicated.
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fractionated by gel filtration chromatography on Ultrogel
AcA44.

The column was calibrated for molecular weight

determination using Blue Dextran, bovine serum albumin,
ovalbumin, pepsin, carbonic anhydrase, and ribonuclease A.
The fractions containing the protein which did not bind
to the DE-52 column, Pool I, were concentrated and applied
to the Ultrogel AcA44 column.

This pool was fractionated

into two peaks of Type V collagen degrading activity
(Figure 7).

The first peak eluted in the void volume (V

0

),

this peak represented a minor portion of the total protein
and enzyme activity.

Its molecular weight (M.W.) was

larger than 200,000 daltons, the exclusion limit for
gel AcA44.
........

Ultro ~

The second peak of Type V collagen degrading

activity generated by Ultrogel chromatography had an
elution volume corresponding to a M.W. of 54,000 daltons.
This peak constituted the majority of the enzyme activity
added and only a minor portion of the total protein in
Pool I.

The majority of the protein in Pool I was of low

M.W., approximately 10,000 daltons.

Pool II, the major peak of Type I collagen degrading
activity from the DE-52 chromatogram, was also chromatographed on Ultrogel.

It was separated into two peaks of

protein and both contained Type I collagen degrading
activity (Figure 8).

The V
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Figure 7.

Ultrogel AcA44 Gel Filtration Chromatography of Pool I.
All fractions in Pool I of the DE-52 chromatogram were
concentrated by pressure dialysis to 1.5 mls and applied
to a column (1.6 x 90 cm) of Ultrogel AcA44 equilibrated
in 0.05M Tris-HCl . pH 7.5 containing O.OlM CaCl2 and 0.02%
NaN3.
Fractions of 1.7 mls were collected and monitored
for absorbance at 280 nm and for Type V collagenase
activity.
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Ultrogel AcA44 Gel Filtration Chromatography of Pool II.
All fractions in Pool II of the DE-52 chromatogram were
concentrated by pressure dialysis to 1.5 mls and applied
to a column (1.6 x 90 cm) of Ultrogel AcA44 equilbrated
with 0.05M Tris-HCl pH 7.5 containing O.OlM CaCl2 and
0.02% NaN3.
Fractions of 1.7 mls were collected and
monitored for absorbance at 280 nm and for Type I
collagenase activity.

(j)

w
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of the total enzyme activity and about 30% of the total
protein applied to the column.

The second peak of enzy-

matic activity eluted in the 60,000 dalton M.W. range.

Pool III which eluted from the DEAE cellulose column
during the 0.3M to 1.0M NaCl gradient, was fractioned into
three peaks of enzyme activity by chromatography on Ultrogel AcA44 (Figure 9).

The V fractions from this chromao

togram contained the majority of the protein that was
loaded on the column.

Both Type I and Type V collagen

degrading activities were detected in these fractions.
The second of the three peaks generated contained only
Type V collagen degrading activity and had a M.W. of
..... approximately 80,000 daltons.

The final peak which eluted

in the 35,000 dalton M.W. range contained Type I co l lag en
degrading activity.

Inhibition of Types I and V Collagen Degrading Activities

Concentrated serum-free media from DLD-1 colon carinoma cells were used as the source of Type I and Type V
collagen degrading activities.

Fetal calf serum, EDTA,

PMSF, dithiothreital (DTT), and N-ethylmaleimide (NEM)
were tested for their ability to inhibit DLD-1 collagen
degrading activities using the standard enzyme assays
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Figure 9.

Ultrogel AcA44 Gel Filtration Chromatography
of Pool III.
All fractions in Pool III of
the DE-52 chromatogram were concentrated by
pressure dialysis to 1.5 mls and applied to
a column (1.6 x 90 cm) of Ultrogel AcA44
equilibrated with 0.05M Tris-HCl pH 7.5
containing O.OlM CaCl2 and 0.02 % NaN3.
Fractions of 1.7 mls were collected and
monitored for Type I and Type V collagenase
activity (Panel A) and absorbance at 280 nm
(Panel B).
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(Table 2).

Both Type I and Type V collagen degrading

activities were inhibited by serum and EDTA, the metalloproteinase inhibitor.

The serine protease inhibitor PMSF

had no effect on Type V collagen degrading activity and
reduced the Type I collagen degrading activity by only 18%.
DTT, which reduces disulfide bonds and maintains sulfhydryl
groups in a reduced state, blocked 41% and 32% of Type I
and Type V collagen degrading activities, respectively.
NEM, which reacts with free sulfhydryl groups, had no effect
on either enzyme activity.

Effects of DMF on the Production of Type I and Type V
Collagenase, Cellular,

and

By DLD-1 Colon

Media Elastase Activities
Carcinoma Cells

The effect of DMF on the production Type I and Type V
collagenase and elastase activities by DLD-1 cells was
determined using late log phase cultures.

The production

of these enzymatic activities was measured over a 24 hour
period.

Enzyme activity was normalized using total cellu-

lar protein and DNA values (Table 3).

DMF caused a 20%

increase in Type I collagenase activity over control
cultures when the activity was expressed per mg of protein.

J

Table

2.

Inhibition of Type I and Type V Collagen Degrading Activities
by Protease Inhibitors.

PERCENT INHIBITION
TYPE V COLLAGENASE2
TYPE I COLLAGENASEl

INHIBITOR

CONCENTRATION

SERUM

5%

78

70

EDTA

10 MM

73

68

PHSF

1 HM

18

0

DTT

10 HM

41

32

NEM

10 HM

0

0

Crude DLD-1 colon Carcinoma Serum-Free Media was used as the source of
collagenase activity in both assays.
1.

Type I collagenase assay was incubated at 35°C for 1 hour.

2.

Type V collagenase assay was incubated at 30°C for 12 hours.

m

00

Table 3.

(1)
Effect of DMF
on Type I pollagenase, Type V Collagenase, Celluar
Elastase, and Media Elastase Production by DLD-1 Colon Carcinoma Cells.

ENZYME ACTIVITY
µg substrate degraded/hr/mg protein

ACTIVITY
MEASURED

CONTROL

DMF

µg substrate degraded/hr/mg DNA
DMF

CONTROL

Type I
Collagenase

7.18 ± 0.80

8.60 ±

0.50*

311 ±

33

773 ±

167*

Type V
Collagenase

0.25 ± 0.03

0.37 ±

0.06*

10 ±

1

34 ±

5*

Cellular
Elastase

0.25 ± 0.04

0.32 ±

0.02*

10 ±

1

30 ±

4*

Media
Elastase

31. 97 ± 2. 80

22. 38 ± 11. 9

1345 ± 108

Results are expressed as the mean ±S.D. with an n
(1)
*

2066 ± 1034

= 4.

Cells were treated with 0.8% DMF for four passages prior to analysis.
Significantly greater than control, p
t test.

< 0.05 determined by unpaired Student's

en

co
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The increase due to DMF was 148 % when DNA was
used to normalize the enzyme values.

Both values for Type

I collagenase activity in DMF cultures were significantly
higher than control values (p < 0.05).

Type V collagenase

activity increased 44% and 220% due to DMF treatment when
enzyme activity was expressed per amount of protein and
DNA,respectively.

DLD-1 cellular elastase activity also

increased as a result of DMF treatment.

Cellular elastase

activity per mg protein increased 31% while elastase
activity per µg DNA increased 192%.

Both values were

significantly higher than control (p < 0.05).

Media

elastase activity per mg protein dropped by 30% in
response to DMF.
.......

ficant (p < 0.05).

This decrease was not found to be signiMedia elastase activit y expressed per

µg DNA increased 53% when the cells were treated with DMF.
This value for enzyme activity in DMF treated culture was
significantly higher than control cultures (p < 0.05).

To

deter~ine

if these increases in activity were associ-

ated with alterations in the levels of cellular protein, DNA
and RNA the levels of these cellular constituents were determined.

Cells were grown

in media containing 0.8 % DMF for

four passages prior to analysis.

DMF caused a significant

rise in the cellular levels of protein and RNA over controls (p < 0.05).

DMF cells contained significantly less
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DNA than control cells (p < 0.05) (Table 4).

Effect of DMF on the Incorporation of
3

H-glycine into Protein

The effect of DMF on the capacity of DLD-1 cells
to synthesize and secrete protein was analyzed by
measuring the rate of incorporation of
TCA insoluble cell and media proteins.

3

H-glycine into
Determinations

were made after three and six hours of growth in media
containing 5 µCi

3

H-glycine/ml.

The results of these

experiments were normalized in two ways; per amount of
cellular protein and DNA.
3
...._

DMF treated cells incorporated

H-glycine into cellular protein at a slower rate than

control cells after three hours of growth in
containing media (Table 5).

3

H-glycine

This decrease was signifi-

cant only when the values were expressed per unit of DNA
(p < 0.05).

However, after six hours of incubation, the

DMF treated cells were incorporating label into cellular
protein at a faster rate than controls.

The DMF values

were significantly greater than controls by both units
of measure (p < 0.05).

Analysis of media proteins revealed that DMF treated
cells were secreting

3

H-glycine containing protein into
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Table 4.

Effect of DMF(l) on Protein, DNA, and RNA Content
of DLD-1 Colon Carcinoma Cells.

CELLULAR CONTENTS
TREATMENT

mg PROTEIN/
CELL x 10- 7

lJg DNA/C~LL

Control

6.89 ± 0.80

1. 64 ±

DMF

8 .13 ± 0.50*

o. 87

x 10-

o. 22 x

± 0.12

lJg

RNA/CELL
x 10- 6

6.11 ± 2.20
9.52 ± 0.83*

Results are expressed as the mean ±S.D. with
an n = 4.
(1)

Cells were treated with 0.8% DMF for four passages prior
to analysis.

*

Significantly greater than control, p < 0.05 determined
by unpaired Student's t test.

x

Significantly greater than DMF, p < 0.05 determined by
unpaired Student's t test.

Table 5.

Effect of DMF(l) on the Incor~oration of 3H-glycine into Cellular Protein of
DLD-1 Colon Carcinoma Cells.

RATE OF INCORPORATION OF
LENGTH OF
INCUBATION
IN LABEL
CONTAINING
MEDIA

CONTROL

3 Hours

553 ± 28

6 Hours

528 ± 41

dpm/mg Protein/hr x 10- 3

dpm/µg DNA/hr x 10-3
CONTROL

DMF

539 ± 122

433 ± 2x

331 ± 6

634 ± 57*

324 ± 2

404 ± 3*

DMF

Results are expressed as the mean ±S.D. with an n
(1)

3 H-GLYCINE

=

3.

Cells were treated with 0.8/. DMF for four passages prior to analysis.

*

Significantly greater than control, p < 0.05 determined by unpaired Student's t test.

x

Significantly greater than DMF, p < 0.05 determined by unpaired Student's t test.

--l

w
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the media at a slower rate than controls at three hours
(Table 6).

The rate of secretion of labeled proetin by

DMF treated cells was significantly slower than control
when expressed per unit of DNA but was not significantly
different per unit of protein (p < 0.05).

At six hours,

the situation had reversed, DMF treated cells were secreting
labeled protein at a faster rate than controls.

This in-

crease was significant only when the data was expressed
per unit of DNA (p < 0.05).

Effect of Cycloheximide on the Synthesis of Connective
Tissue Degrading Enzymes

by

Control and DMF Treated

DLD-1 Cells

Control and DMF treated DLD-1 cells were treated with
cycloheximide to determine if the effects of DMF were
dependent on the synthesis of protein.

Cells were exposed

to 1 µg cycloheximide/ml for the 24-hour period during
which enzyme production was quantified.

Treatment of DMF

treated DLD-1 cells with cycloheximide resulted in a small
decrease in Type I collagenolytic activity expressed per
unit of protein and an insignificant increase in activity
per unit of DNA (p < 0.05) (Table 7).

Cyclobeximide bad

the same effect on control cells; synthesis of Type I

Table 6.

Effect of DMF(l) on the Incor~oration of
DLD-1 Colon Carcinoma Cells.

3

H-glycine into Media Protein of

RATE OF INCORPORATION OF
LENGTH OF
INCUBATION
IN LABEL
CONTAINING
MEDIA

dpm/mg Protein/hr
CONTROL

DMF

3

H-GLYCINE
dpm/µg DNA/hr

CONTROL

DMF

3 Hours

4811 ± 455

3450 ± 1078

374 ± 46 x

213 ± 65

6 Hours

5750 ± 1014

7309 ± 1110

353 ± 65

464 ± 47*

Results are expressed as the mean ±S.D. with an n = 3.
(1)

Cells were treated with 0.8% DMF for four passages prior to analysis.

*

Significantly greater than control, p < 0.05 determined by unpaired Student's t test.

x

Significantly greater than DMF, p < 0.05 determined by unpaired Student's t test.

'I
CJ1
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Table 7.

Effect of Cycloheximide(l) on Type I Collagenase
Production by Control and DMF Treated(2) DLD-1
Colon Carcinoma Cells.

TYPE I COLLAGENASE ACTIVITY
µg collagen degraded/hr
/mg protein

TREATMENT

Ilg collagen degraded/hr
/mg DNA

Control

7 .18 ± 0.8

311 ±

Control +
Cycloheximide

6.27 ± 0.7

458 ± 145

DMF

8.60 ± 0.5*

773 ± 167*

8.54 ± 2.7

867 ± 200*

33

........

DMF +
Cycloheximide

Results are expressed as the mean ± S.D. with an
= 4.

n

(1)

Cells were treated with 1 µg cycloheximide/ml.

(2)

Cells were treated with 0.8% DMF for four passages prior
to analysis.

*

Significantly greater than control or control + cycloheximide,
p < 0.05 determined by unpaired Student's t test.
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collagenolytic activity was diminished but not comnletely
abolished.

Cycloheximide treatment could not inhibit the

increase in Tvpe I collagenolytic activity nroduced by
DMF treatment.

Treatment of DMF and control DLD-1 cells with
cycloheximide effected the synthesis of Type V collagenolytic activity in a manner similar to that seen with
Type I collagenolytic activity.

Increases in Type V

collagenolytic activity due to DMF were still present
when DMF and control cells were treated with cycloheximide; however, the magnitude of the increase was less
(Table 8).
....._

DMF treated cells treated with cycloheximide

produced significantly more Type V collagenolytic activity than control cells treated with cycloheximide
(p <

0.05).

A similar pattern of reduction in the DMF effect

upon treatment with cycloheximide was seen with cellular
elastase activity (Table 9).

DMF treated cells treated

with cycloheximide produced significantly more cellular
elastase activity than control cells treated with cycloheximide when the activity was expressed per unit of DNA
(p < 0.05).

The increase was not significant when

expressed per unit of protein.
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Table 8.

Effect of Cycloheximide(l) on Type V Collagenase
Production by Control and DMF Treated(2) DLD-1
Colon Carcinoma Cells.

TYPE V COLLAGENASE ACTIVITY
µg collagen degraded/hr
/mg protein

TREATMENT

µg collagen degraded/hr
/mg DNA

Control

0.25 ± 0.03

10. 6 7 ± 1.24

Control +
Cycloheximide

0.22 ± 0.01

16. 52 ± 4.40

DMF

0.37 ± 0.06*

34.20 ± 5.20*

0.30 ± 0.06*

31.30 ± 5 .16*

--DMF +
Cycloheximide

Results are expressed as the mean ± S.D. with an
= 4.

n

(1)

Cells were treated with 1 µg cycloheximide/ml.

(2)

Cells were treated with 0.8% DMF for four passages prior
to analysis.

*

Significantly greater than control or control + cycloheximide,
p < 0.05 determined by unpaired Student's t test.
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Table 9.

Effect of Cycloheximide(l) on Cellular Elastase
Production by Control and DMF Treated(2) Colon
Carcinoma Cells.

ELASTASE ACTIVITY
µg elastin degraded/hr
/mg protein

µg elastin degraded/hr
/mg DNA

Control

0.25 ± 0.04

10.30 ± 1. 70

Control +
Cycloheximide

0.23 ± 0.03

13.15 ± 1.90

DMF

0.32 ± 0.02*

30.14 ± 4.10*

0.24 ± 0.06

24.77 ± 4.50*

TREATMENT

......._

DMF +
Cycloheximide

Results are expressed as the mean ± S.D. with an
4.

n =

(1)

Cells were treated with 1 µg cycloheximide/ml.

(2)

Cells were treated with 0.8% DMF for four passages prior
to analysis.

*

Significantly greater than control or control + cycloheximide,
p < 0.05 determined by unpaired Student's t test.
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A markedly different result due to cycloheximide
treatment was obtained when media elastase activity was
measured.

Treatment of control cells with cycloheximide

resulted in a small decrease in media elastase activity
per unit of protein and a small but insignificant
increase in activity per unit of DNA (p < 0.05) (Table 10).
These results were analogous to those seen for Type I and
Type V collagenase and cellular elastase.

However, when

DMF treated DLD-1 cells were treated with cycloheximide
media elastase activity increased above the levels seen
in cultures treated with DMF alone.

These increases were

significant when the activity was expressed per unit of
protein and DNA (p < 0.05).
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Table 10.

Effect of Cycloheximide(l) on Media Elastase
Production by Control and DMF Treated(2) DLD-1
Colon Carcinoma Cells.

ELASTASE ACTIVITY
µg elastin degraded/hr
/mg protein

TREATMENT

µg elastin degraded/hr
/mg DNA

Control

31.97 ± 2.8

1345 ±

108

Control +
Cycloheximide

30.70 ± 11. 0

1959 ±

91 4

DMF

22.38 ± 11.9

2066 ± 1034

DMF +
Cycloheximide

52.68 ± 20.6

5151 ±

814*

Results are expressed as the mean ± S.D. with an
= 4.

n

(1)

Cells were treated with 1 µg cycloheximide/ml.

(2)

Cells were treated with 0.8% DMF for four passages prior
to analysis.

*

Significantly greater than control + cycloheximide, p < 0.05
determined by unpaired Student's t test.
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DISCUSSION

Type V Collagen Purification and Type V Collagenase Assay

In order to study the degradation of Type V collagen
by tumor proteases a fairly large quantity of the protein in
purified form was needed.

Human placentas were a good

source of Type V collagen since they were easily obtainable and contained fairly large quantities of collagenous
proteins.

Initial attempts to purify Type V collagen

utilized the whole placenta.

It was later found advan-

tageous to use only the amnionic membrane as the starting
material since Type V collagen comprises a greater portion
~of

the total collagen present in anmions than in whole

placentas (Sage and Bornstein, 1979).

The exact molecular

configuration of Type V collagen is not established, many

°'

preparations are composed of two different °'chains,

°'

l(V) and

2(V) in a 2: 1 ratio (Rhodes and Miller, 1978;

Bentz et al, 1978; Burgeson et al, 1976).

A third°' chain

d\3(V) has been isolated from whole placenta but is
absent from amnionic membranes (Sage and Bornstein, 1979).
The Type V collagen purified in this study was of the configuration

cA

~chains

are in close agreement with those reported by

l(V) ,
2

<::\ 2(V).

Rhodes and Miller (1978).

The molecular weights of the

The purified material was
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labeled via an acetylation reaction and used as the substrate in the Type V collagenase assay.

Due to the high

specific activity of the substrate (1.12 x 10 6 dpm/mg) only
20 µg of collagen per assay was required to maintain a
linear rate of degradation for the duration of the assay.

The Type V collagenase assay developed offered several
improvements over existing methods.
as an incubation temperature.

This assay used 30°C

This temperature is several

degrees below the temperature at which the Type V collagen
triple helix begins to unfold (-33°C)(Rhodes and Miller,
1978).

Other assays used to measure Type V collagen de-

grading activity have used incubation temperatures of
~32.5°C

and 37°C (Mainardi et al, 1980a;Liotta et al, 1980).

At these temperatures the Type V collagen helix may be
starting to unfold or may be partially denatured and nonspecific degradation of the molecule may occur.

Using

30°C as the incubation temperature, degradation of the
substrate by non-collagenase proteases is minimized.

The degradation products formed during the reaction
between enzyme and substarte were separated from nondegraded substrate molecules using dioxane/methanol.

This

solvent precipitates native substrate molecules but not
degraded denatured molecules.

Dioxane was first used in
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in Type I collagenase assay by Terato et al (1976).

The

precipitating solvent was later modified by adding
methanol (4:1 dioxane/methanol)(Lindblad and Fuller, 1982).
They found the addition of methanol increased the precipitating efficiency of the solvent.

The degradation products

formed by three different collagenases exhibit differences
in their solubility in dioxane/methanol.

Mammalian colla-

genases are known to make one cleave in the collagen helix
producing two specific reaction products (Gross and Nagai,
1965) where as bacterial collagenase digests the molecule
into many low molecular weight peptides (Nagai et al, 1960).
The larger reaction products produced by the mammalian
collagenases precipitated at lower dioxane/methanol concentrations than the more extensively degraded bacterial
collagenase reaction products.

The solubility differences

between mammalian and bacterial collagenase reaction products are most likely due to the size of the fragment
formed and the degree to which the fragment retains a
helical structure.

23% dioxane/methanol was chosen as the

standard concentration for the assay because native and
denatured substrate molecules are maximally separated at
this concentration and 25%-50% of the total enzyme activity
produced by the mammalian collagenases could be detected.
Others have used 50% dioxane to precipiate non-degraded
Type V collagen (Mainardi et al, 1980a).

In this assay,
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the addition of 50% dioxane would allow the detection of
less than 15% of the total radioactivity solubilized by
DLD-1 and alveolar macrophage collagenases.

The addition

of small quantities of highly radioactive collagen and the
improved precipitating solvent increases the sensitivity
of the assay.

If one unit of enzyme activity is defined

as 1 µg of collagen degraded per minute at 30°C, the assay
can detect as little as 13 mU of enzyme activity.

Similar

substrates and precipitating solvents have been used in
Type I collagenase assays and detection limits of 15 mU of
enzyme activity were reported (Lindblad and Fuller, 1982).

Levels of Connective Tissue Degrading Enzymes in
Normal Fibroblasts, DLD-1 Colon Carcinoma, and
B16-F10 Melanoma Cells

The levels of collagenolytic and elastolytic activity
measured in these three cell lines are not easily compared
to published values for other cell lines because of variations in the type of substrate used and the temperatures
at which the assays were performed.

Fibroblasts are one

of the highest collagenase producers, collagenase protein
represents 6% of the total protein exported by these cells
(Valle and Bauer, 1979).

DLD-1 colon carcinoma cells pro-

du c ed levels of collagen degrading activity that were com-
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parable to those produced by normal dermal fibroblasts.
DLD-1 cells produced considerably more collagenolytic
activity than highly metastatic B16-Fl0 murine melanoma
cells.

Bl6-F10 cells are a subline of the B16 melanoma

parent line which have been selected in vivo and in vitro
for their ability to form experimental metastases (Fidler,
1973).

The location of elastase activity appears to vary
with different cell types (Werb et al, 1982).

The elastin

degrading activity produced by DLD-1 cells was found almost
exclusively in the culture medium.

Elastases from pan-

creatic cells and macrophages are also secreted into the
growth medium (Barrett et al, 1980; Banda and Werb, 1981).
Elastolytic activity has also been detected in the media of
cultured human breast carcinoma cells (Kao et al, 1982).
The elastin degrading activity produced by the normal fibroblasts and B16-F10 cells was found in both the cellular
compartment and the media, with a greater portion being
cell-associated.

Hornebeck et al (1980) bas detected

elastase activity in the Triton X-100 extracts of fibroblasts and smooth muscle cells.

Neutrophil elastase is

also known to be localized intracellularly (Werb et al,
1982).
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Characterization of DLD-1 Collagen Degrading Activities

One of the objectives of this study was to analyze
the collagen degrading activities produced by DLD-1 cells
to determine if Type I and Type V collagen were degraded
by the same or different enzymes.

DEAE cellulose partially

separated Type I and Type V collagen degrading activities.
All of the Type I collagen degrading activity added to the
column bound and eluted in two peaks.

DLD-1 Type I colla-

gen degrading activity appears to be an anionic protein
since it bound to the positively charged resin.

The small

peak of activity which eluted during the second gradient
may be the same Type I collagenolytic activity complexed
~ to

a more strongly anionic media protein allowing a

stronger interaction between the column and protein to
occur.

Protein-protein interactions involving colla-

genase and other culture media proteins has been documented (Fiedler-Nagy et al, 1976).

Huang and Abramson

(1975) and Woolley et al (1973) have characterized Type I
collagenase from guinea pig and human skin cells as
anionic proteins, the DLD-1 Type I collagenolytic activity
appears to be similar to these enzymes.

Several other

Type I collagenases have been characterized and exhibit
opposite charge properties.

Rheumatoid synovial colla-
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genase and rabbit

v2

ascites tumor collagenase fail to

bind to anionic resins (Woolley et al, 1975a, McCroskery
et al, 1975).

Type I collagenase from human skin fibro-

blasts appears to have the capacity to bind to both
anionic and cationic resin under similar conditions
(Stricklin et al, 1977; Woolley et al, 1973).

The majority of the Type V collagen degrading
activity in DLD-1 media did not bind to the DEAE column
while a minor portion bound tightly.
appears to be cationic in nature.

This protein

The minor fraction of

the Type V collagenolytic activity which did bind to the
column may be a complex of enzyme and another media protein which binds tightly to column.

These results were

different from those obtained by Mainardi et al (1980a)
who separated macrophage Type I and Type V collagenolytic
activities.

All the Type V collagen degrading activity

from macrophages bound to DEAE cellulose.

The difference

in the physiochemical properties of these two Type V
collagenolytic activities may simply reflect a difference
in enzymes derived from macrophages and neoplastic
epithelial cells.

Although the majority of Type V

collagenolytic activity from DLD-1 cells failed to bind
to the column, DEAE cellulose chromatography was an effective method for partially separating Type I and Type V
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collagen degrading activities.

The two partially separated collagenase activities
were further purified and characterized by gel filtration
chromatography on Ultrogel AcA44.

The Type V collagen

degrading activity which did not bind to the DEAE column
was fractionated into two peaks of enzymatic activity by
gel filtration chromatography.

The major peak of enzyme

activity from the Ultrogel chromatogram eluted in the
54,000 dalton M.W. range.

A small peak of enzymatic

activity was present in the V , indicating a M.W. of
0

200,000 daltons or greater.

Large M.W. peaks of enzyme

activity have been encountered during collagenase purifications (Fidler-Nagy, 1977; Woolley et al, 1973; Huang
and Abramson, 1975; Brikedal-Hansen et al, 1976).

These

peaks may be polymers of enzyme molecules or complexes of
enzyme molecules and fragments of the collagen substrate
(Woolley et al, 1973; Fidler-Nagy, 1977).

Presently, only

three Type V collagen degrading activities have been
reported (Liotta et al, 1980; Mainardi et al, 1980a; Rich
et al, 1983), and only one study has reported a M.W.
Reticulium cell sarcoma Type V collagenolytic activity
has a M.W. of 80,000 daltons (Liotta et al, 1980).

The

difference in M.W. between DLD-1 Type V collagen degrading activity and the reticulium cell sarcoma activity may
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represent a difference in the enzyme produced by two
different cell types.

Alternatively, the activity re-

ported by Liotta et al (1980) may be a complex of enzyme
and a collagen degradation fragment.

The major peak of Type I collagen degrading
activity from the DEAE chromatogram was also fractionated into two peaks of enzymatic activity by Ultrogel
chromatography.

One peak eluted in the V

0

complex of collagenase and collagen.

and may be a

Native collagens

have M.S.'s of approximately 300,000 daltons and would
elute from the Ultrogel column in the V •
0

Collagenases

are known to bind tightly to their substrates (Stricklin
et al, 1978).

The second peak of activity eluted in the

60,000 dalton M.W. range.

This M.W. is in agreement with

M.W.'s reported for Type I collagenases isolated from two
other carcinoma cell lines.

A M.W. of 63,000 daltons was

reported for a rat prostate carcinoma collagenase (Huang
et al, 1979) and 68,000 daltons has been cited as the M.W.
of Type I collagenase from a squamous cell carcinoma of
the parotid gland (Huang et al, 1982).

These minor dif-

ferences in M.W. may be due to the different types of gel
filtration media used in each study.

A third Type I

collagenase isolated from an ascitic carcinoma cell line
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has been characterized and a M.W. of 42,000 daltons was
reported (Wolf and Wirl, 1982).

The differences in M.W.

between the ascites cell enzyme and the other Type I
collagenases may be due to the presence of substrate
fragments complexed with the enzyme or the same collagenases originating from different species or tissues may
simply be heterogeneous.

The third pool of collagen degrading activity generated by DEAE cellulose was fractionated into three peaks
of activity by gel filtration chromatography.
peak of activity was found in the V

A high M.W.

and contained both

0

Type I and Type V collagenolytic activities.

As in the

two previous gel filtration chromatograms this peak was
probably an enzyme-substrate complex.

A peak of Type V

collagenolytic activity eluted at a volume corresponding
to 80,000 daltons.

Liotta et al (1980) has also reported

80,000 daltons as the M.W. of a reticulium cell sarcoma
Type V collagenolytic activity.

The third peak of activity

generated by Ultrogel chromatography had a M.W. of 35,000
daltons and contained predominately Type I collagenolytic
activity.

This activity has a M.W. similar to Type I

collagenase purified from rabbit v
genates (McCroskery et al, 1975).

2

ascites tumor homo-
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Type I collagenase from cultured human skin fibroblasts has been extensively characterized and two species
of enzyme of different M.W. (45,000 and 50,000 daltons)
have been separated (Stricklin et al, 1977; Stricklin et
al, · 1978).

The two enzyme were immunologically similar as

determined by immunodiffusion.

They were also found to

have similar amino acid compositions, cyanogen bromide
peptide analysis revealed 9 peptides from each enzyme, 8
of which were common to both activities.

Trypsinization

could not convert the higher M.W. enzyme into the smaller
one, the two proteins were considered to be different
species of the same enzyme.

DLD-1 colon carcinoma cells

may also synthesize two different Type I and Type V colla......._

gen degrading activities.

Since these activi t i e s are not

highly purified it is possible that the larg e M.W. forms
of each collagenase may be a complex of enzyme and substrate fragment.

The two types of chromatography used in

this study were adequate methods for partiall y separating
DLD-1 Type I and Type V collagenolytic activities and
estimating their M.W.

However, these methods were unable

to completely separate the enzymes from a large M.W. protein, mostly likely their substrate.

The complete separa-

tion of the enzymes from their substrates may require more
extreme purification conditions.

The addition of urea or

Triton X-100 to the buffer systems or heating the enzyme
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containing sample to 60°C prior to subsequent purification steps have all been used to completely dissociate
collagenases from their substrates (Harris and Vater,
1982).

Type I and Type V collagenolytic activities from
DLD-1 cells were found to have similar inhibition profiles.

The Type V collagen degrading activities reported

by Mainardi et al (1980a) and Liotta et al (1980) were
characterized as metalloproteinases and had no serine protease activity.

The DLD-1 Type V collagen degrading

activity can be similarly characterized since it was
inhibited by EDTA but not PMSF.

All Type I collagenases

have been characterized as metalloproteinases and are
uneffected by serine protease inhibitors (Harris and
Vater, 1982).

The DLD-1 Type I collagenolytic activity

is predominately a metalloproteinase.

A non-collagenase

enzyme having serine protease activity may also be present in the crude collagenase preparation.

This activity

could act on the substrate following the initial cleavage
of the triple helix by the collagenolytic metalloproteinaseactivity.

Collagenase from a rabbit

v2

ascites cell

carcinoma was inhibited by DTT (McCroskery et al, 1975) as
were both Types I and V collagen degrading activities from
DLD-1 cells.

These enzymes may require intact disulfide
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bond for maximal activity since the reducing agent (DTT)
diminished enzymatic activity.

Effects of DMF on DLD-1 Colon Carcinoma Cells

The effects of DMF on the turmorigenicity, morphology
and in vitro growth properties of DLD-1 colon carcinoma
cells has been examined (Dexter et al, 1979; Dexter and
Hager, 1980).

In vitro DMF reduces the growth rate of

DLD-1 cells and causes the cells to enlarge (Dexter et al,
1979).

DMF treated cells appear less round and more

"leafy" than untreated cells.

Concommitant with these

morphological changes phase optic microscopy has revealed
~ that

DMF treated cells have a higher cytoplasmic to nuclear

ratio (Dexter et al, 1979).

In this study cells treated

with DMF contained more protein and RNA per cell and less
DNA per cell than control cells.
ment with those obtained

by

This finding is in agree-

phase optic microscopy.

Treatement of DLD-1 cells with DMF resulted in the
increased production of Type I and Type V collagenase and
cell-associated elastase activities.

It is unlikely that

DMF had a selective effect stimulating the production of
these particular proteases.

The increases in enzymatic
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activity probably resulted from a non-specific increase in
the rate of protein synthesis.

This hypothesis, however,

cannot explain the decrease in media elastase activity seen
in DMF treated cultures.

This decrease was not statisti-

cally significant and the value may be erroneous since the
corresponding standard deviation was very large.

To determine if the effect of DMF on protease production was the result of an increased rate of protein synthesis, the rate of incorporation of
tein was measured.

3

H-glycine into pro-

After three hours of growth in label

containing media, the DMF cultures appeared to be incorporating label slower than control cultures, although the
.......

decrease was significant only when the data were expressed
per unit of DNA.

After six hours of growth, the DMF

cultures were synthesizing protein faster than controls.
This increased rate of protein synthesis could explain the
increased levels of Type I and Type V collagenases and
cellular elastase activities present in DMF treated cultures.

The decreased rate of incorporation of 3 H-glycine

seen in DMF treated cells at the three hour point may not
be a true indicator of decreased macromolecule synthesis,
the decrease could have resulted from an initial lag in
the rate of glycine penetration into the cells.

DMF treat-

ment may have altered the cell membrane configuration
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resulting in a decreased rate of amino acid uptake.

After

longer growth periods in label-containing media sufficient
quantities of

3

H-glycine may have entered the DMF treated

cells and allowed their rate of protein synthesis to exceed
controls.

If the DMF effect on enzyme production was due to
increased enzyme biosynthesis, blockade of protein synthesis with cycloheximide should inhibit the effect.

Con-

trol and DMF treated cultures were treated with 1 µg cycloheximide/ml, a dose which inhibited collagenase production
by endotoxin-activated macrophages (Wahl et al, 1974).

The

effect of DMF on Type I and Type V collagenolytic activ~i ties

was still apparent however, in the presence of cyclo-

heximide.

This result indicated that DMF could produce

its effect independent of protein synthesis.

It has been

reported that collagenases are synthesized and stored
intracellularly as zymogens (Harper et al, 1971).

The DMF

treated cells may have synthesized and stored intracellularly greater quantities of these enzymes prior to the
inhibition of protein synthesis.

The increased levels of

these enzymes seen in DMF treated cells treated with cycloheximide could have been the result of the release of
greater quantities of stored enzyme.
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When DMF treated cells were exposed to cycloheximide
for 24 hours, the cells secreted large amounts of elastase
into the media.

Control cells did not respond to cyclo-

heximide in the same manner.

There was no significant

difference in media elastase levels in control and control
cells treated with cycloheximide, this was analogous to the
effects on collagenolytic activities.

The elastase

activity secreated by DMF treated cells following cycloheximide treatement most likely originated from a preexisting intracellular store of enzyme.

Cycloheximide

has been shown to effect the turnover of tyrosine transaminase in cultured liver cells leading to increased
levels of transaminase activity (Kenney, 1967; Hershko and
Tomkins, 1971).

It was postulated that the s y nthesis of

proteases responsible for the degradation of intracellular
proteins are more sensitive to cycloheximide treatment than
the synthesis of tyrosine transaminase (Kenney , 1967).
DLD-1 elastase levels may have been increased due to
decreased intracellular degradation of the enz yme.
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CONCLUSIONS

1.

Type V collagen was purified from human amnions,
labeled and used as a substrate in an improved
assay for measuring Type V collagen degrading
activity.

Non-degraded substrate molecules were

separated from degraded substrate fragments by
precipitation with 23% dioxane/methanol.

2.

DLD-1 colon carcinoma cells, B16-Fl0 murine
melanoma cells, and normal dermal fibroblasts
produced proteases which could degrade Type I
and Type V collagen and elastin.

3.

Type I and Type V collagen degrading activities
secreted by DLD-1 cells were characterized as
metalloproteinases.

These activities were

partially separated using DEAE cellulose chromatography.

4.

Two forms of DLD-1 Type I collagenolytic activity
were partially purified and had molecular weights
of 60,000 and 35,000 daltons.
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5.

Two forms of DLD-1 Type V collagenolytic activity
were partially purified and had molecular weights
of 80,000 and 54,000 daltons.

6.

DMF treatment increased the production of Type I
and Type V collagenolytic activities and cellassociated elastinolytic activity by DLD-1 cells.

7.

DMF treatment increased the cellular protein and
RNA content and decreased the DNA content of DLD-1
cells.
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